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Abstract 
 
Background 
 Adolescence and young adulthood are critical life stages for maintaining sexual 
and reproductive health (SRH), especially for women. There is a vast research literature 
dedicated to the determinants of young women’s SRH and related risk behaviors—e.g., 
contraception and condom use. While the factors influencing women’s SRH are broadly 
understood, it is less clear how risk mechanisms operate within specific contexts. 
Illuminating the unique settings that exacerbate or mitigate young women’s SRH risks 
could guide the development of more potent interventions. 
 This dissertation examines young women’s SRH in the context of international 
travel. Traveling to a foreign country precipitates an abrupt shift in women’s 
psychosocial, physical, and cultural environments that may, in turn, influence SRH risk 
behaviors. Existing studies focus on travelers’ sexual behaviors in predominantly 
European and clinic-based samples. Data for women are mostly limited to prevalence 
estimates. Notably, no published studies report on women’s use of contraception, other 
than condoms, during international travel. With few studies comparing travelers with 
non-travelers, it is also unclear whether SRH outcomes are attributable to travel itself or 
if high-risk individuals disproportionately engage in international travel.   
 
Data Source 
 We conducted a mixed-methods study of female university students who had 
traveled outside the United States in the past three months (“Traveler”) or planned to do 
so in the next three months (“Pre-Traveler”). Participants had a history of sex with men 
and considered the United States their home country. For the quantitative study, 
Travelers, (n=340) and Pre-Travelers (n=170) completed a cross-sectional online survey 
about their SRH and recent or upcoming trip (“index trip”). In the retrospective portion of 
the survey, Travelers reported on their index trip and Pre-Travelers for a recent period of 
similar duration in the United States. The qualitative study consisted of in-depth, semi-
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structured interviews with 25 Travelers and 19 Pre-Travelers. This dissertation is 
presented in three manuscripts, whose aims, methods, and results are described below. 
 
Manuscript 1 
 Aim: To evaluate whether traveling internationally increases young women’s risk 
of adverse SRH outcomes, compared to not traveling. Methods: Using multivariable 
modified Poisson regression, we estimated relative risk of contraceptive lapse (errors or 
non-adherence) and new male sexual partnership associated with international travel 
(Travelers) versus staying in the United States (Pre-Travelers). Results: During 
international travel, women were no more likely to lapse on their contraception (RR 1.05, 
95% CI 0.83—1.32) but were 70% more likely to report a new male sex partner (RR 
1.71, 95% CI 1.07—2.74). 
 
Manuscript 2 
 Aim: To describe the prevalence and correlates of contraceptive lapse among 
young women during international travel. Methods: In this exploratory analysis of 
surveyed Travelers (n=340), we examined crude bivariate associations between 
contraceptive lapse and potential correlates in three domains: baseline/pre-travel 
variables, travel characteristics and experiences, and SRH-related travel variables. 
Correlates associated with lapse at p<.20 were evaluated using multivariable modified 
Poisson regression, including two sensitivity analyses restricted to pill users and women 
who had sex while traveling. Results: Prevalence of contraceptive lapse was 29% overall 
and especially high among pill users (50%) and travelers who had trouble communicating 
with male sex partners about contraception (57%). Multivariable correlates of lapse were: 
using the pill (RR 4.51, 95% CI 2.57—7.94) compared to other or no contraception; trip 
duration of >30 days versus 1-7 days (RR 2.02, 95% CI 1.14—3.57); having trouble 
communicating with a male sex partner about contraception (RR 1.79, 95% CI 1.16—
2.75); a high perceived impact of language barriers (RR 1.77, 95% CI 1.02—3.08); and 
perceiving local access to abortion as difficult (RR 1.67, 95% CI 1.22—2.27). There was 
a trend toward increased lapse risk among participants who had difficulty maintaining 
their contraceptive schedule while traveling across time zones (RR 1.38, 95% CI 1.00—
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1.91). Findings were generally similar in sensitivity analyses except for attenuation in the 
effect for pill use among sexually active travelers (RR 2.47, 95% CI 1.14—5.35). 
 
Manuscript 3 
 Aim: To characterize the spectrum and antecedents of young women’s sexual and 
contraceptive behaviors during international travel. Methods: We analyzed qualitative 
interview transcripts to identify themes related to: (1) Participants’ pre-travel 
expectations of sex; (2) The circumstances surrounding their sexual encounters with men 
while traveling; (3) Negotiation of condoms and contraception with these sex partners; 
and (4) Facilitators and barriers affecting contraceptive adherence. Results: Participants 
frequently expected to be abstinent during travel, citing myriad rationales that included 
personal values, no perceived opportunities for sex, and the nature of the trip. Some 
Travelers had unexpected sexual encounters, which were typified by health-promoting 
behaviors but also by unprotected sex, substance use, and condom errors. New sexual 
partnerships were fueled by increased attention from men, situational disinhibition, and 
heightened intimacy among travel companions. We observed an array of contraceptive 
considerations brought on by international travel—e.g., procuring extra supplies, 
adjusting schedules, and maintaining use during air travel—and obstacles that triggered 
contraceptive lapses and discontinuation. The logistical requirements of travel magnified 
differences between contraceptive methods: challenges were most acute for pill users, 
while women with intrauterine devices appreciated their maintenance-free contraception. 
 
Conclusion 
 Young women may be at higher risk of new sexual partnership during 
international travel, while contraceptive lapse is frequent in both travel and non-travel 
settings. During international travel, risk of contraceptive lapse varies by women’s 
chosen contraceptive method as well as trip-specific factors. Pre-departure counseling by 
clinicians and other travel specialists should address travel-related barriers to women’s 
contraceptive use, prepare women for the possibility of unexpected sexual encounters, 
and encourage behavioral strategies that prevent both unintended pregnancy and sexually 
transmitted infections. 
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Preface 
 
The manuscripts presented in this dissertation were prepared independently for 
submission to peer-reviewed journals. As such, there is redundancy in content between 
the manuscripts and the introductory material in Chapter 1.   
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Chapter 1 
 
Introduction 
 
I. The Sexual and Reproductive Health of Young Women in the United States 
  
 Sexual and reproductive health (SRH) is especially salient during women’s 
adolescence and early adulthood. Just over half (54%) of women in the United States are 
sexually active by age 18 and 74% are by age 20.1 Major cultural shifts in marriage, 
cohabitation, and family formation have occurred over the past half-century. Women are 
postponing or forgoing marriage, are cohabiting more frequently outside of marriage, and 
are delaying their first birth (to age 26, on average).2,3 Taken together, these trends 
underscore why avoiding health risks associated with sexual relationships—namely, 
unintended pregnancies and sexually transmitted infections (STIs)—is paramount for 
young women who have sex with men. Indeed, epidemiological data indicate that 
adolescent and young adult women bear the brunt of these adverse outcomes.  
 
A. Public health significance of unintended pregnancy and STIs in the United States 
 Public health entities4—and most sexually active people5—support the notion that 
pregnancy is best when planned. Yet, 45% of pregnancies in the United States are 
unintended at the time they are conceived and, despite indications of a decline from 
2008-2011,6 this percentage has remained relatively stable over the past 20 years.7 In 
2011, there were 2.8 million unintended pregnancies, or 45 per 1,000 women of 
reproductive age.6 About half of all US women have one by age 45.8 The consequences 
of unintended pregnancy are myriad: they disproportionately end in abortion, 
compromise the socioeconomic well-being of families, and are associated with poor 
outcomes for mothers and children including delayed prenatal care, prenatal substance 
use, low birthweight, maternal depression, and children’s poor mental health.9,10 The 
sequelae of unintended births are particularly acute for parenting youth whose 
educational and vocational trajectories are hindered by childrearing responsibilities.11  
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 The impact of STIs on individuals and society is often underappreciated due to 
the stigma surrounding them. HIV remains incurable despite therapeutic advances that 
have stemmed morbidity and mortality. Other viral STIs such as herpes simplex virus and 
human papillomavirus (HPV) also have potential life-long effects. HPV is responsible for 
nearly all cases of cervical cancer, 95% of anal cancers, 70% of oropharyngeal cancers, 
65% of vaginal cancers, 50% of vulvar cancers, and 35% of penile cancers.12 When left 
untreated, bacterial STIs such as chlamydia can cause pelvic inflammatory disease, 
ectopic pregnancy, and tubal infertility.13 During pregnancy, STIs carry risk of 
miscarriage, stillbirth, premature birth, low birthweight, and neonatal infections.14,15 The 
financial costs of STIs are considerable—$15.6 billion for the 19.7 million Americans 
diagnosed in 2008.16 HIV accounted for more than 80% of those costs. 
 
B. Descriptive epidemiology of unintended pregnancy and STIs in the United States 
Adolescence and early adulthood are peak risk periods for adverse SRH 
outcomes. The proportion of pregnancies that is unintended is highest among 18- to 19-
year-old women (76%) and also higher among women ages 20-24 (59%) relative to the 
national average (Table 1).6 These proportions are also disproportionately high among 
cohabiting women (56%) or never-married, non-cohabiting women (81%) compared to 
married women (24%).6 National incidence rates of unintended pregnancy are also 
highest among women ages 18 to 29, and 20-29 year-old women contribute the greatest 
volume of unintended pregnancies.6 The epidemiology of unintended pregnancy is also 
Table 1. Incidence of unintended pregnancy and sexually transmitted infections among 
women by age, United States 
 
Unintended pregnancy—20116 Chlamydia—201517 Gonorrhea—201517 
 % of all 
pregnancies 
Rate per 1,000 Rate per 100,000 Rate per 100,000 
Age:     
15-19  75% 41 2,994 442 
   15-17 72% 20 -- -- 
   18-19 76% 71 -- -- 
20-24 59% 104 3,730 547 
25-29 42% 76 1,619 302 
TOTALa 45% 45 646 107 
aDenominator includes US women ages 15-44 for unintended pregnancy and all ages for STIs. 
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notable for significant disparities by income and race/ethnicity. Rates for African 
American women exceed whites at all income levels.6 At the same time, rates for women 
living below the federal poverty level exceed 90 per 1,000 in all racial/ethnic categories.6 
 The US Centers for Disease Control and Prevention (CDC) estimates that youth 
ages 15 to 24 account for 50% of the nation’s incident STIs.18 In 2008, this amounted to 
9.8 million cases of chlamydia, gonorrhea, syphilis, herpes, HPV, hepatitis B, HIV, and 
trichomoniasis among young people.19 The morbidity of chlamydia and gonorrhea 
infections is particularly high for young women (Table 1). In 2015, 29% of reported 
chlamydia cases among women were in 15-19 year-olds and 57% were among women in 
their twenties; proportions were similar for gonorrhea.17 For both infections, incidence 
rates among young women are many times greater than the overall rate. 
 
C. Key determinants of young women’s sexual and reproductive health       
 There is a voluminous literature dedicated to the determinants of young women’s 
SRH. Like other aspects of human health, SRH is multifactorial.  
In the 1970s, Bronfenbrenner articulated an “ecology of human development” wherein 
multiple levels of the social environment interact to shape an individual’s behavior.20 His 
seminal work has inspired many iterations of the ecological or “social ecological” model, 
which public health practitioners are increasingly using to understand health behaviors 
and design effective interventions,21 including for SRH.22-24  
 We propose a social ecological framework to illustrate the key domains and 
factors affecting young women’s SRH (Table 2). Each factor influences the likelihood of 
one or more SRH outcomes—sex with male partners, contraception use, condom use, 
acquiring STI, becoming pregnant, or having an abortion. Below, we briefly summarize 
the literature pertaining to these determinants, with select citations.  
Policy. The policy landscape includes many potent factors that govern the  
legality, availability, and accessibility of SRH services. First, funding allocated through 
the federal budget supports SRH programs dedicated to prevention, diagnosis, and  
treatment. Publicly funded programs including Medicaid and Title X helped avert an 
estimated two million unintended pregnancies, one million unintended births, and nearly  
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700,000 abortions in 2010.25 Second, federal and state laws affect women’s access to 
contraception. As of January 2013, the contraceptive coverage mandate under the 
Affordable Care Act requires insurance plans to cover the full range of contraceptive 
drugs and devices approved by the US Food and Drug Administration (FDA) without co-
pays. An evaluation of state laws from 1998-2010 found that insured women in states 
requiring coverage of FDA-approved contraceptives were significantly more likely than 
women in other states to be using effective contraception; no association was found for 
uninsured women.26 Third, policies define the conditions under which women access the 
SRH services they desire. Women who wish to use a hormonal method of contraception 
(e.g., the pill) must first visit a healthcare provider and obtain a prescription. Providers, 
researchers, and legislators have argued that this requirement constitutes a barrier to 
Table 2. Key determinants of young women’s sexual and reproductive health*  
 
Policy 
Factors 
 
Laws defining legality and accessibility of SRH services 
Public funding for SRH services 
Coverage of SRH services by health insurance plans 
Drug and device regulations 
 
Community 
Factors 
Cultural norms  
Religious teachings 
Media messages 
Formal education systems 
Availability and cost of SRH services 
 
Interpersonal 
Factors 
Peer and family norms  
Parental monitoring  
Encounters with healthcare providers 
 
Male sex partners:  
   Relationship duration, level of commitment, concurrency 
 Communication & cooperation in contraceptive use 
 Contraceptive knowledge, skills, & attitudes  
 Biological: Fertility, infection status 
 
Individual 
Factors 
Biological: Age, fertility, cervical ectopy, immune status, comorbidities 
Contraceptive knowledge, skills, & attitudes  
Substance use 
Values and religiosity 
Health insurance 
Financial resources 
 
*Outcomes=having sex with men, using contraception/condoms, pregnancy, STI, and abortion. 
EC=emergency contraception; SRH=sexual and reproductive health; STI=sexually transmitted infection.  
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access and that pharmacists and self-screening checklists can ensure women’s safety.27,28 
Fourth, abortion is one of the most controversial and legislated medical procedures in the 
United States. Federal and state laws address every facet of abortion care including the 
gestational limits for procedures, clinicians’ counseling scripts, and the width of 
facilities’ hallways.29 Lastly, there are regulatory policies affecting SRH services. Drugs, 
medical devices, and diagnostic tests are regulated under the FDA and undergo extensive 
review before being approved for market distribution. While health risks are sometimes 
identified during post-market surveillance, these processes help ensure the safety and 
effectiveness of SRH services that women access through clinics or retail locations. 
Community. This level considers women’s physical and social environments 
(beyond peers and families, described below). First, whether defined by geography, 
cultural identity, or something else, all communities have norms that delineate sanctioned 
behaviors. Within religious communities, norms are often conveyed explicitly in 
teachings about sex, contraceptive, use, and abortion. Other norms are not easily 
attributable to a source, but are nonetheless widely recognized and often reinforced in the 
media (e.g., gender roles, premarital sex). In studies of US adolescents, community 
norms exert independent effects on SRH risk behaviors.30,31 Second, formal education 
systems foster the literacy and numeracy skills that women use to make SRH decisions. 
Lastly, healthcare providers are a vital community resource for sexually active young 
women. The affordability, convenience, breadth, and quality of SRH services offered in a 
woman’s community serve to catalyze her contraceptive intentions.32-34  
Interpersonal. Influential members of women’s social spheres include peers, 
family members, and healthcare providers. Norms within peer groups and families are 
strong predictors of youth’s decisions regarding sex, contraception, and abortion.24,34,35 
Parental monitoring is linked to delays in sexual debut and adolescents’ lower STI risk; 
it’s unclear whether parental effects persist into early adulthood.24 Healthcare providers 
are a primary source of information for young women during visits for primary care, 
contraception, and STI services.36 Provider counseling fosters the many prevention 
behaviors that undergird women’s sexual and reproductive well-being.32,34  
Sex is a dyadic event that involves male partners in several ways. First, an eligible 
sexual partner must exist in a woman’s social network. Second, women cite partner 
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preferences as one factor affecting their decision to have unprotected sex.34 Women’s 
contraceptive choices also depends on relationship factors such as duration, level of 
commitment, and concurrency (vs. monogamy).37 In newer or less committed 
partnerships, women are more likely to use condoms because they provide simultaneous 
protection against pregnancy and STIs. As relationships become more serious, pregnancy 
prevention becomes the dominant motivation and couples trade condoms for more 
effective contraceptive methods.37 Third, sex-dependent contraceptive methods such as 
condoms and withdrawal depend on successful communication with, and cooperation 
from, male partners. Fourth, new partners are predictive of incident STIs in longitudinal 
studies of female adolescents38 and university students.39 Preventing pregnancy and STIs 
requires communication, negotiation, and trust between partners—qualities that may be 
lacking in a new partnership. Lastly, there are biological characteristics: infertile and STI-
negative partners eliminate the risk of pregnancy and STI acquisition, respectively.  
Individual. Several individual-level factors relate to biology. First, sexual 
initiation is a developmental milestone that becomes increasingly probable with age. In a 
nationally representative survey conducted in 2009, only 6% of 14 to 15 year-old females 
reported vaginal sex in the past month compared to 62% of 20 to 24 year-olds and 74% 
of women ages 25 to 29—the highest percentage by age category.40 Trajectories of sexual 
risk also accelerate through adolescence and peak in the early 20s.41,42 Second, women in 
their 20s are at peak fertility, having achieved menstrual regularity but not yet 
experienced age-related fertility declines.43 Third, young women are more likely to have 
cervical ectopy, a hormonally mediated phenomenon hypothesized to facilitate STI 
acquisition.44 Fourth, women’s immune status affects their susceptibility to infection. 
Those who receive the bivalent or quadrivalent HPV benefit from virtually complete 
(95%) protection.45 However, women are at risk of re-infection from bacterial STIs 
because they confer no long-term immunity. Lastly, women’s co-morbidities affect their 
medical eligibility for specific contraceptive methods,46 and their decisions to continue 
using a given method highly depend on which side effects they experience.34  
Women’s contraceptive knowledge, skills, and attitudes influence which 
method(s) they select and how well they adhere to that method(s).32 Method choices carry 
significant implications for pregnancy and STI prevention. Nearly 7 in 10 US women 
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aged 15-24 who use contraception rely on either the pill or condom, methods that require 
high behavioral compliance and are thus prone to user error.47 Only 0.3% of women will 
become pregnant with a year of perfect pill use, but 9% will under scenarios of “typical” 
use.48 The gap in effectiveness between perfect and typical use is even greater for 
condoms (2% vs. 18%).48 Furthermore, women dissatisfied with pills or condoms are less 
likely to use them consistently.49 In a cohort study of family planning clinic patients, 
women who initiated long-acting reversible contraception (intrauterine device or 
implant)—methods requiring no ongoing behaviors—had significantly higher rates of 12-
month continuation and satisfaction compared to women who started the pill, patch, or 
ring.50 Women’s expectations and preparations also influence whether they use any 
method: running out of supplies, not having contraception on hand, and not expecting to 
have sex are associated with engaging in unprotected sex.34  
Other miscellaneous factors round out this level of our framework. First, 
substance use is known to impair decision-making and is often implicated in youth’s 
risky decisions. However, its causal relationship with sexual risk-taking (e.g., unprotected 
sex) and SRH outcomes remains unclear.51-53 Second, normative influences from the 
community and interpersonal domains are filtered through a woman’s moral-ethical 
framework and the depth of her religious beliefs. Lastly, access to SRH services depends 
on women’s insurance status and their personal financial resources. 
 
II. International Travel as a High-Risk Context for Young Women’s Sexual and 
Reproductive Health 
 
A. Increasing prevalence of international travel 
 International travel is increasingly popular among US residents. In 2016, over 68 
million trips originated from the United States, an 8% increase over 2013.54 Travel to 
Mexico or Canada comprised 56% of these trips, with destinations outside of North 
America accounting for the remainder. In a 2015 survey of international travelers 
conducted by the US Department of Commerce, 53% reported vacation as their primary 
purpose, 27% visiting friends or relatives, and 10% business or convention travel.55 
Women comprised 50% of all travelers, up from 39% in 2000.56  
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 For youth, one popular form of international travel is studying abroad. In the 
2014-2015 academic year, 314,515 US students studied abroad for academic credit and 
22,181 traveled internationally for work, internships, or volunteering.57 The number of 
students participating in study abroad programs has more than tripled over the past 20 
years.57  
 
B. Clinical perspectives on the health risks of international travel  
 Traveling to another country brings unique health considerations. The CDC’s 
Travel Health website, a popular resource for expectant travelers and healthcare 
providers, makes recommendations for managing travel health risks based on 
destination.58 Travelers with “more complex itineraries or…health problems” are advised 
to seek care from a travel medicine clinic prior to their departure for vaccinations, 
prophylactic medications, and counseling on how to stay healthy during travel.58 Many 
travel risks are infectious in nature—e.g., malaria, rabies, yellow fever, and pathogens 
transmitted through food and water—but others include sunburn, altitude sickness, motor 
vehicle accidents, drowning, and violence. 
 Over the past two decades, the SRH risks of international travel have garnered 
increasing concern. Clinical practice guidelines for travel medicine frequently emphasize 
pre-departure counseling on STI prevention.59-61 In comparison, unintended pregnancy 
has received considerably less attention as a travel health concern. The CDC’s Travel 
Health website did not explicitly address pregnancy prevention or contraceptive 
counseling until the spread of Zika virus in 2016; even then, recommendations center on 
pregnant women, couples planning to conceive, and travelers to Zika-endemic regions.62 
In their more extensive “Yellow Book” written for travel medicine health professionals, 
the CDC urges providers to “caution the traveler to avoid activities that can lead to 
[STIs], unwanted pregnancy, or bloodborne infections” and “remind travelers to use 
condoms if they have sex.”61 Yellow Book recommendations do not include assessment 
of female travelers’ current contraceptive methods or the adequacy of their contraceptive 
supplies for the trip’s duration. However, some clinical practice articles63-65 and a 
textbook on travel medicine66 underscore the importance of contraceptive counseling 
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during the travel medicine visit. Commentaries by Glasier67 and Patton68 in 1999 
advocate for advanced provision of EC as a critical health service for female travelers. 
 
C. Potential impact of international travel on young women’s sexual and reproductive 
health  
 We posit that SRH determinants take on a unique structure in the context of 
international travel and amplify some of the risk pathways we described above for 
women’s routine (non-travel) settings. While some elements of the conceptual framework 
in Table 2 carry forward to the travel context—e.g., women’s contraceptive 
knowledge—travel may introduce many novel factors (Table 3), particularly at levels 
above the individual. We highlight some potential, travel-specific influences below.    
 Policy. Nations have unique policy infrastructures and SRH laws are particularly 
variable between countries.69 Travelers may not be able to access the SRH services they 
are accustomed to in the United States. Abortion is essentially legal throughout most of 
Western Europe, Australia, and Central Asia, but highly restricted in other regions.70 
Foreign countries might also lack regulatory structures for monitoring the safety of drugs 
and devices, both pre- and post-market. The CDC warns travelers of the potential for 
counterfeit medications abroad.71 Thus, even when locally accessible, SRH supplies (e.g., 
contraception and condoms) may be of questionable safety and effectiveness. Laws 
regarding drugs and alcohol are also relevant, for example: which substances are legal; 
the age at which they can be purchased and consumed; and the locations and times they 
are sold. More permissive substance laws, such as minimal legal drinking ages of 16-18 
throughout Europe,72 may foster substance use and relatedly, sexual risk-taking. Lastly, 
travelers may have difficulty accessing local SRH services due to coverage (or lack 
thereof) under their health insurance plans. 
 Community. International travelers are often immersed in environments that are 
starkly different from their home country. First, cultures with more permissive norms  
around casual sex and substance use may encourage travelers to engage in riskier 
behaviors. Second, women who need SRH services while traveling are affected by their 
availability and cost. For women traveling to remote or underdeveloped areas, access to 
services may be hampered by poor transportation infrastructures. Third, crime—a  
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concern for any international traveler—may include theft of luggage or purses that 
contain women’s contraceptives. Lastly, local STI/HIV prevalence affects women’s risk 
from having sex with a local partner. During travel, women may be exposed to pathogens  
that are not endemic to the United States. 
Interpersonal. International travel might also change the composition of women’s 
immediate social environments. Travelers’ social networks—traveling companions, new 
acquaintances, and perhaps local residents—are potential sexual networks. Young female 
travelers with more autonomy may have more opportunities for exploring sexual 
partnerships compared to women on highly supervised trips. Both US travel medicine 
providers and healthcare providers in the travel destination can potentially influence 
women’s contraceptive use while abroad. Local providers’ counseling messages about 
SRH and management of SRH conditions may depart from practices in the United States. 
Table 3. Potential determinants of young women’s sexual and reproductive health in the 
context of international travel*  
 
Policy 
Factors 
 
Local laws regarding SRH services and substance use 
Local regulatory policies for drugs and devices 
Coverage of international SRH services under health insurance plans 
 
Community 
Factors 
Cultural norms regarding SRH, gender roles, and substance use  
Local healthcare infrastructure 
Local transportation infrastructure 
Local crime rate 
Local STI/HIV prevalence 
 
Interpersonal 
Factors 
Social network during travel 
Degree of autonomy / supervision  
Encounters with US and local healthcare providers 
 
Male sex partners:  
   Language 
   Norms regarding SRH and gender roles 
   Relationship timeline 
   Sexual assault 
 
Individual 
Factors 
Perceptions of anonymity, liminality, disinhibition 
Substance use during travel 
Pre-travel expectations and preparations 
Shifts in daily routines 
Knowledge of local SRH resources 
Biological: Menstrual cycle regularity, travel illness  
 
*Outcomes=having sex with men, using contraception/condoms, pregnancy, STI, and abortion. 
EC=emergency contraception; SRH=sexual and reproductive health; STI=sexually transmitted infection.  
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As with SRH in general, travel sexual partners can be expected to play a 
prominent role in women’s SRH. Unique aspects of travel partnerships include possible 
language barriers as well as discrepant norms regarding partners’ roles and 
responsibilities in preventing pregnancy and STIs. Qualitative research with female 
leisure travelers suggests a role for “time compression” in the rapid intensification of 
travel partnerships.73,74 Compressed courtships may not engender the familiarity, trust, 
and rapport that underlie couples’ pregnancy and STI prevention practices. Unwanted 
sexual experiences are also a risk while traveling abroad.75,76  
Individual. First, we consider the psychosocial environment of international 
travel. Travel is frequently a novel and exciting experience that provides an escape from 
the demands of everyday life. Researchers have conceptualized the psychological state of 
travel as one of “situational disinhibition,”77,78 “the relaxation of social and moral 
constraints,”79 liminality,80 and anonymity.81 These conditions may cause travelers to 
engage in behaviors—e.g., casual sex, unprotected sex, substance use—that they 
ordinarily would not. Indeed, fun and relaxation are often the primary motivation for 
taking a trip overseas. Second, travelers’ preparedness with contraceptive supplies 
depends on whether they expect to be sexually active. Third, long travel itineraries and 
restructuring of daily routines may disrupt women’s pill-taking schedules. Fourth, even 
travelers with high contraceptive knowledge and self-efficacy may not know where to 
find SRH services locally. Timely access to EC is critical for travelers who have 
unprotected sex and want to avoid pregnancy. Finally, we consider biological factors 
specific to travel. Flying across multiple time zones disrupts travelers’ circadian rhythms, 
resulting in jet lag82 and potentially, changes in the menstrual cycle.83 Diarrhea and 
vomiting, common complaints among international travelers,60 may decrease the 
absorption and efficacy of contraceptive pills.84 
 
D. Empirical findings related to women’s sexual and reproductive health during 
international travel  
 We reviewed the literature for any quantitative studies examining any of six SRH 
outcomes among populations of female international travelers: new sexual partnership, 
unexpected sex, unprotected sex (inconsistent or no condom use), contraceptive use, 
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unintended pregnancy, and STI acquisition. We included studies that reported the 
prevalence or correlates of these outcomes, as well as those evaluating international 
travel as a risk factor (i.e., comparing travel with non-travel.) Our search yielded 38 
articles85-121 representing 34 samples of women and a 2010 meta-analysis79 that pooled 
data from 15 of these samples. Studies reporting prevalence and correlates, the most 
frequently reported estimates, are summarized in Tables 4 and 5, respectively. Most 
studies include both genders, but we only feature data for women in the tables. These 
findings consist mostly of unadjusted prevalence estimates because many authors pool 
male and female travelers in their analyses of SRH correlates. The literature is comprised 
of predominantly European samples recruited from STI clinics, hostels, and other high-
risk settings. Only one study was based on a sample of exclusively US residents (Peace 
Corps volunteers).113 We summarize the evidence below, mostly just for women, but we 
highlight select results derived from combined samples of male and female travelers.  
 New sexual partnership. New sexual partnership is the most commonly reported 
outcome. A few studies report on “casual” partners, but usually include new partners in 
their definitions. Pooling data from 13 studies of female travelers, Vivancos et al. 
estimate a prevalence of 19.5% (95% CI 12.4–27.8%). The wide range in estimates—
from 2% to 62%, including 11 studies not featured in the meta-analysis—reflects the 
heterogeneity in sample characteristics. Studies also vary in their prevalence calculations. 
For example, some include women with regular partners (a low-risk group for new 
partnerships) or do not describe the relationship status of their sample. Others count non-
travelers in their denominators when calculating prevalence of new travel sex partners 
among clinic attendees or population-based samples.86-88,94,98,100,117 The studies also vary 
in the type of travel considered—for instance, any in past 12 months versus a single trip. 
 Seven studies report correlates of women’s new travel partnerships and all control 
for one or more variables in their analyses. Three of these studies87,98,117 use long 
reference periods for travel (lifetime or past 5 years), consider correlates that might have 
occurred after travel, and feature non-travelers in their reference groups. In the 
remaining, higher-quality studies examining more recent travel,102,109,114,116 the most 
consistent correlates are younger age and having a pre-travel expectation of sex. Analyses 
of mixed-gender samples identify the following statistically significant (p<.05) positive
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Table 4. Summary of studies reporting prevalence of sexual and reproductive health outcomes among female international travelers 
Citation Design Sample  Travel type Results 
Vivancos 
201079 
Meta-
analysis  
15 studies of women’s sexual behavior during 
foreign travel  
Various New sex partner: 20%, 95% CI 12-
28% (pooled from 13 studies)a 
• Unprotected sex: 62%, 95% CI 
53-71% (pooled from 4 studies)a 
INCLUDED IN VIVANCOS ET AL: 
Abdullah 
199885 
Cross-
sectional  
86 women departing Hong Kong airport. Ages 18-
65.b 57% married.b 27% Chinese, 55% Caucasian.b  
Any in past 12 months; 
destination N/S 
 
New sex partner (strangerc): 41% 
Arvidson 
1996,86 
1997;87 
Mardh  
199688 
Cross-
sectional  
996 family planning clinic patients in Sweden. Mean 
age=26. Relationship status during travel N/S. 
 
Lifetime; destination N/S New sex partner: 28%a 
Positive STI test: Any (26%), HPV 
(11%), chlamydia (10%)  
 
Batalla-
Duran 
 200389 
 
Cross-
sectional  
70 UK residents departing Tenerife airport in 2002. 
Ages 15-62 (mean: 30).b 51% in a relationship. 
 
Recent trip to Tenerife New sex partner: 39% 
Bellis 
200490 
Cross-
sectional  
661 UK residents departing Ibiza airport. Ages 16-
35. 24% traveled with regular partner.b  
 
Recent trip to Ibiza Any sex partner: 54%  
• Unprotected sex: 43% 
Bloor  
199891 
Cross-
sectional 
Population-based sample of 392 UK residents ages 
18-34b who traveled without a partner. 
 
Any in past 2 years; 
destination N/S 
New sex partner: 4% 
• Unprotected sex: 25% 
Carter  
199792 
Cross-
sectional 
112 STI clinic patients in Glasgow. Ages 17-55 
(mean: 26). 34% traveled with partner.b  
 
Any in past 3 months; 
74% Western Europe* 
New sex partner: 20% 
• Unprotected sex: 50% 
Croughs  
200893 
Cross-
sectional 
1,049 travel clinic patients in Belgium. Ages 16-50 
(mean: 29).b 61% traveled with partner.b  
 
Recent trip ≤4 weeks 
long; 31% Africa, 23% 
Asia, 21% Turkey* 
New sex partner: 2% 
• Unprotected sex: 71% 
• Unexpected sex: 75% 
Daniels  
199294 
Cross-
sectional 
116 STI clinic patients in the UK. Ages 18-64 (mean: 
27). Relationship status during travel N/S. 
Any in past 6 months; 
various destinations 
New local sex partner: 9%a 
• Unprotected sex: 75% 
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Table 4. Summary of studies reporting prevalence of sexual and reproductive health outcomes among female international travelers 
Citation Design Sample  Travel type Results 
Hawkes  
199495 
Cross-
sectional 
303 tropical medicine clinic patients in the UK. Mean 
age: 29. Relationship status during travel N/S.  
 
Most recent trip in past 2 
years; various 
destinations 
 
New sex partner: 16% 
Hawkes  
199596 
Cross-
sectional 
199 STI clinic patients in the UK. Mean age: 30.b 
72% single.b  
 
Recent trip in past 3 
months; destination N/S  
New sex partner: 18%  
 
Mendelsohn 
199697 
Cross-
sectional 
216 STI clinic patients in the UK. Ages 17-45 
(median: 25).b Relationship status during travel N/S.  
 
Any in past 6 months; 
72% Europe 
New sex partner: 19% 
• Unprotected sex: 58% 
Mercer  
200798 
Cross-
sectional 
Population-based sample of 6,399 UK residents 
sexually active in past 5 years. Ages 16-44.b 
Relationship status during travel N/S.  
 
Any in past 5 years; 
various destinations 
New sex partner: 7%a 
Nemoto  
200799 
Cross-
sectional 
 
132 Japanese tourists, students, and temporary 
workers. Ages 18-59.b 15% married.b 
Past 12 months in Hawaii 
 
New sex partner: 19%  
Tveit  
1994100 
Cross-
sectional 
188 STI clinic patients in Norway. Age N/S. 
Relationship status during travel N/S.  
 
Any in past 5 years; 
various destinations 
New sex partner: 34%a 
 
Davies  
2011101 
Cross-
sectional 
207 backpackers staying in Australian hostels. Ages 
18-30 (median: 23). 87% European.b 17% traveling 
with regular partner. 
 
Current, including to 
Australia (median: 4 
months) 
New sex partner: 62% 
• Unprotected sex: 61% 
Positive for chlamydia: 3% 
de Graaf 
1997102 
Cross-
sectional 
230 Dutch expatriates. Mean age=37. 35% single. Recent long-term (>2 
years) post to countries 
with high HIV prevalence 
New sex partner: 17% 
Unprotected sex: 16-19% by 
partner type 
 
Egan  
2001103 
Cross-
sectional 
231 backpackers from 33 countries. Ages 15-34.b 
58% in relationship with partner back home. 
Current trip to Canada New sex partner: 20% 
Last travel sex unprotected: 41% 
 
Gagneux RCT 541 travel clinic patients in Switzerland. Age<35. Recent trip; 40% sub- Casual sex partner:d 4% 
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Table 4. Summary of studies reporting prevalence of sexual and reproductive health outcomes among female international travelers 
Citation Design Sample  Travel type Results 
1996104 Relationship status during travel N/S. 
 
 
Saharan Africa, 36% 
Asia* 
• Unprotected sex: 54%  
 
Hughes  
2009105 
Cross-
sectional 
340 UK backpackers staying in hostels. Ages 18-35 
(51% 21-24 years old). 21% traveling with long-term 
partner.b 
 
Current travel in Australia 
(>2 weeks) 
Unprotected sex: 46% 
Kaehler  
2013106 
Cross-
sectional 
148 backpackers from Western Europe, North 
America, and Australia. Ages 18-63 (mean: 27).b 
Unmarried. 
 
Current travel in Thailand New sex partner: 12% 
• Unprotected sex: 25%  
Lewis 
2016107 
Cross-
sectional 
684 backpackers (77% from Europe) departing on 
boats to Thai islands. Ages 17-44. All single. 
 
Current travel in Thailand New sex partner: 29% 
• Unprotected sex: 37% 
Martin  
2012108 
Cross-
sectional 
80 German volunteers who had completed 
international service project. Ages 18-30.b 
Relationship status during travel N/S. 
 
Post for ≥ 6 months, 65% 
to Latin America* 
Unintended pregnancy: 3% (n=2) 
Maticka-
Tyndale  
1998109 
Cross-
sectional 
375 Canadian college students on Spring Break. 
Ages 18-30.b 35% in long-term relationship. 
 
Current or recent 1-week 
trip to US  
New sex partner: 13%  
Pre-travel intention of new sex 
partner: 11% 
 
Matteelli 
2013110 
Cross-
sectional 
31,574 patients seen at 52 global surveillance 
clinics for STI evaluation. Relationship status during 
travel N/S. 
 
Current or recent travel; 
various destinations 
Test positive for STI: 0.4% 
McNulty 
2010;111  
Wand  
2011112 
Cross-
sectional 
2,937 backpackerse attending Australian STI clinic. 
Mean age: 25. 5% married or cohabiting.  
 
 
Current travel in Australia Unprotected sex in past 3 months, 
if sexually active: 75% 
 
STI positivity: 5% chlamydia, 9% 
genital warts, 4% herpes  
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Table 4. Summary of studies reporting prevalence of sexual and reproductive health outcomes among female international travelers 
Citation Design Sample  Travel type Results 
Moore  
1995113 
Cross-
sectional 
720 randomly sampled US Peace Corps volunteers 
in 28 countries. 75% under age 30. Not married or 
cohabitating. 
 
Current long-term travel 
on Peace Corps mission 
New sex partner: 60% 
Ragsdale 
2006114 
Cross-
sectional 
128 tourists in Costa Rica. Ages 18+ (52% <23 
years). Single and not traveling with men. 
Current travel in Costa 
Rica for <3 months 
New sex partner: 47%  
• If sex expected pre-travel: 62% 
• If sex not expected pre-travel: 
32%  
 
Senn 
2011115 
RCT 594 travel clinic patients in Switzerland. Ages 18-
44.b Not traveling with regular partner. 
 
Single trip; destination 
N/S 
New sex partner: 14% 
 
Sundbeck 
2016116 
Cross-
sectional 
Population-based sample of 464 Swedish residents 
reporting sex during recent travel. Ages 18-29.  
 
Most recent trip in past 12 
months 
Casual sex partner:f 19% 
• Last sex unprotected: 59% 
Tanton 
2016117 
Cross-
sectional 
Population-based sample of 6,399 UK residents 
sexually active in past 5 years. Ages 16-74. 
Relationship status during travel N/S. 
 
Any in past 5 years New sex partner: 11% (ages 16-
34), 2% (ages 35-74)a 
Whelan  
2013118 
Cohort 365 travel clinic patients in The Netherlands. Median 
age: 25. Relationship status during travel N/S. 
 
Trip lasting 3-12 months; 
31% Southeast Asia, 30% 
South Americab 
Casual sex partner:g 32% 
 
aDenominator includes non-travelers. bCharacteristic refers to combined sample of men and women. cLocal resident, other tourist, or sex worker. dSomeone 
other than a steady partner. eForeign born, lived outside of Australia for most of past 5 years, and been in Australia for <2 years or self-identifies as “traveler.” 
fPrevious partner, friend, casual contact, commercial sex partner, or other non-regular partner. gAs defined by participant. CI=confidence interval, N/S=not 
specified, STI=sexually transmitted infection, UK=United Kingdom, US=United States. 
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Table 5. Summary of studies reporting correlates of new sexual partnership or unprotected sex among female international travelers 
Citationa Correlates: New sexual partnership Correlates: Unprotected sex 
Arvidson 
1996,86 
1997;87 
Mardh  
199688 
Current substance use, higher education, history of abortion/STI, 
current HPV infection, parity. Adjusted for age.b 
 
 
 
Bloor  
199891 
 Local sex partner, multiple travel sex partners, no pre-travel 
expectation of sex, did not carry condoms, received health 
advice from family vs. healthcare provider. Mutually adjusted in 
model. 
 
de Graaf 
1997102 
Younger age, pre-travel expectation to have sex, single at 
departure. (NS: Destination, duration, HIV prevalence at 
destination, and feeling lonely, challenged, homesick, bored, or 
freedom during trip). Adjustment variables not specified 
Not carrying condoms. (NS: Age, urbanization, duration, pre-
travel intention to have sex, relationship status at departure, 
destination, HIV prevalence at destination, number of casual 
travel partners, alcohol use prior to or during travel sex, 
subjective attitudes toward sex.) Adjustment variables not 
specified. 
 
Maticka-
Tyndale 
1998109 
Proportion of peers who had sex, peer pact to have casual sex. 
Adjusted for prior sexual behavior and intentions. 
 
 
Mercer  
200798 
Age <25, unmarried, and SRH in past 5 years (greater number 
of partners, sex with women, STI diagnosis, HIV test). Adjusted 
for other sociodemographic characteristics.b 
 
 
Moore  
1995113 
 Older age, higher number of sex partners, high perceived 
personal risk of HIV. Adjusted for trip duration, substance use, 
and perceived severity of HIV risk in host country. 
 
Ragsdale 
2006114 
Pre-travel expectation to have sex, annual income <$10,000. 
Adjusted for sexual impulsivity and travel companions (NS: Age, 
education, ethnicity, student status, condom attitudes, alcohol 
 
 19 
Table 5. Summary of studies reporting correlates of new sexual partnership or unprotected sex among female international travelers 
Citationa Correlates: New sexual partnership Correlates: Unprotected sex 
use, previous sexual risk behavior.) 
 
Sundbeck 
2016116 
Age<25, trip duration ≥1 month, heavy drinking or drug use 
during trip. Adjusted for parental education and self-rated mental 
health.c 
 
Age<25 and trip duration ≥1 month. Adjusted for parental 
education, self-rated mental health, and heavy drinking and drug 
use during trip.c 
Tanton 
2016117 
Age <25, unmarried, and SRH in past 5 years (greater number 
of sex partners, partner concurrency, STI diagnosis, HIV test). 
Adjusted for other sociodemographic characteristics. 
 
 
aRefer to Table 4 for full description of study characteristics. bReference group includes non-travelers. c“Casual” partner: Previous partner, friend, casual contact, 
commercial sex partner, or other non-regular partner. NS=not statistically significant, STI=sexually transmitted infection, UK=United Kingdom. 
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correlates for having a new travel sex partner: younger age;85,89,91,118,122,123 being single, 
traveling alone, or traveling without a steady partner; 91-93,96,104,118,124 longer duration of 
travel;91,95,103,106,113,122-126 pre-travel expectations to have sex,91,93,103,115,122 take 
condoms,115 or use condoms;103 bringing condoms on the trip;91,103 alcohol intake during 
travel;91,126,127 prior travel to the destination;104,106 pre-travel history of “casual 
sex”;91,93,103,104,115 number of lifetime casual sexual partners;103 and number of partners in 
the 12 months before travel.126 Two studies find higher prevalence of new sexual partners 
among men or women traveling for leisure versus other reasons,91,93 while others identify 
business travel as higher risk92 or find no significant differences by travel purpose.128  
 Very few studies address whether new sex partnership is more likely during travel 
versus home. In the only study to look at women, Sundbeck et al. use a case-crossover 
design with a sample of Swedish women to partition women’s past 12 months into time 
spent abroad and time at home.120 They observe a five-fold increased risk of casual sex 
associated with international travel (IRR 5.31, 95% CI 4.27—6.60). Two cross-sectional 
studies ask women to retrospectively report their pre-travel behaviors, which they then 
compare with travel behaviors.99,100 These studies are vulnerable to considerable recall 
bias and report inconsistent findings. A more rigorous cohort study by Vivancos et al. 
examines the sexual behavior of 427 male and female college students in the UK. 
Compared to students who are in the UK over summer break, those who travel abroad are 
2.5 times more likely to have a new sexual partner (adjusted RR=2.06, 95%CI 1.10-
6.06).121 However, the authors do not provide results stratified by sex.  
 Unexpected sex. Three studies examine unexpected sex for female travelers. 
Among travel clinic attendees in Belgium, 75% of women with new travel partners had 
not expected to have sex on their trip (a statistically significantly higher proportion 
compared to men).93 In the second sample of single women visiting Costa Rica, new sex 
partners are more common among those who had anticipated having sex, but nearly one-
third of women who had no expectations report a new travel sex partner.114 In the last 
study, Canadian university students traveling on Spring Break report new sexual 
partnerships at a similar level to their pre-travel expectations (13% vs. 11%, 
respectively).109 In mixed-gender samples, between 33%103 and 55%129 of travelers with 
new partners had not expected to have one on their trip.  
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 Unprotected sex. Most studies report prevalence of unprotected sex only for 
female travelers with new partners. In the Vivancos et al. meta-analysis, this (pooled) 
prevalence is 62.1% (95% CI 52.8-70.9%).79 Individual study estimates range from 25% 
to 75%. Results for five studies not included in the meta-analysis show a similar spread: 
25% (backpackers in Thailand) to 61% (backpackers in Australia).101,106 Five other 
studies calculate prevalence of unprotected sex for all female travelers, not just those with 
new sex partners. Estimates range from 16% (Dutch expatriates on long-term 
assignments) to 75% (backpackers in Australia).102,111  
Four studies evaluate multivariable correlates of women’s unprotected sex during 
international travel. In a sample of UK residents reporting travel in the past two years 
without their partner, having unprotected travel sex is associated with having a local sex 
partner, having multiple travel sex partners, not expecting to have sex prior to departure, 
not carrying condoms, and receiving health advice from family members rather than a 
health care provider.91 De Graaf et al. support the findings for condoms but note lack of 
statistical significance for many other correlates, including pre-travel intentions to have 
sex.102 In a sample of Peace Corps volunteers, women reporting unprotected sex are 
older, have more sex partners, and, puzzlingly, have a high perceived personal risk of 
HIV infection.113 Lastly, in a sample of female Swedish travelers, young age (<25 years) 
and traveling for more than one month are correlates of unprotected travel sex. Studies 
using combined samples of men and women report inconsistent findings. Some find 
independent effects for number of travel sex partners,118,130 not carrying condoms.93,107 
Non-significant correlates include age,90,93,103,118,126 travel purpose,93,97 destination,93,118 
alcohol use during travel,90,126 and pre-travel expectations to have sex93,115 or take 
condoms.115 Findings are very mixed for relationship status, travel companions, travel 
duration, drug use during travel, and pre-travel sexual history. 
 There are no methodologically sound comparisons of women’s condom behaviors 
while traveling versus at home. One study compares women’s unprotected sex with 
casual sex partners—54% during travel vs. 36% prior to their departure—but pre-travel 
measures are retrospectively reported and the authors don’t specify confidence limits or 
the reference period for home behaviors.104  
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 Use of contraception. There are no studies reporting on women’s use of 
contraception (other than condoms) while traveling internationally. 
 Unintended pregnancy. One small study reports on unintended pregnancy among 
traveling women. In a survey of 80 German women, ages 18 to 30, who recently 
completed an international service project for at least six months, two (2.5%) participants 
report having unintended pregnancies during their post in Latin America.108 
 STI acquisition. Five studies describe STI test results for women who are 
formerly or currently traveling abroad, and mostly recruited from clinical sites. Among 
276 attendees of a Swedish STI clinic who report having a new sex partner during any 
international trip in their lifetime, 26% tested positive for at least one infection.88 With 
such a long reference period, it is unlikely that all these infections were acquired during 
international travel. Bavastrelli et al. took a similar approach in their study of 88 women 
recruited from obstetrics/gynecology or infectious/tropical disease clinics in Rome.119 
Among 57 women with any history of international travel, 26% tested positive for 
chlamydia. STI positivity is considerably lower (0.5%) in a sample of over 31,000 
travelers seen at STI clinics in a global surveillance network.110 In another sample of 
2,940 STI clinic attendees backpacking in Australia, prevalence ranges from 0% 
(syphilis) to 9% (genital warts).111 In a smaller sample of 207 backpackers recruited from 
Australian youth hostels, 2.9% tested positive for chlamydia.101  
 The Australian STI clinic study is the only one to estimate multivariable 
correlates of STI acquisition for female travelers. For chlamydia, correlates include 
having three or more partners in the past three months, inconsistent condom use in the 
past three months, and presenting due to a known STI contact; age, marital status, alcohol 
use, and prior chlamydia diagnosis are not statistically significant.112 Two other studies 
feature combined samples of male and female travelers, both recruited from STI clinics, 
with limited findings. In multivariable analysis, Matteelli et al. note positive associations 
between laboratory-confirmed STI and travel purpose (visiting friends or relatives vs. 
tourism), shorter trips (<30 days), and some travel regions.110 The other study finds no 
significant correlates of travel-associated infections in their unadjusted analyses.96 
 Four studies of STI in women compare international travelers and non-travelers. 
In unadjusted analyses, the Australian STI clinic study finds significantly higher 
 23 
positivity for chlamydia, but lower positivity for warts, among travelers.111 Pooling crude 
data from three studies, Vivancos et al. report significantly higher odds of incident STI 
for women with history of a new travel partner (OR 2.45, 95% CI 1.95-3.09).79 However, 
two of these studies report non-significant findings after adjustment88 and the third relies 
on self-reported infections over a five-year recall period.98  
 Other findings. While reviewing the literature for SRH outcomes, we identified 
some other pertinent findings that we briefly review here. First, four studies describe 
travelers’ attitudes and concerns regarding SRH risks; none report findings restricted to 
women. In a sample of UK volunteers, a higher percentage report being concerned about 
STI/HIV upon arriving at their destination (23-25%) compared to pre-departure (5%).131 
Another group of travelers attending a Swiss travel clinic report no such change in STI 
risk perception; however, their perceptions of STIs as a travel risk are significantly lower 
compared to an expert panel of physicians and travel health consultants.132 US study-
abroad participants rank STIs 13th among 18 travel health threats in terms of likelihood as 
well as worry.133 Finally, in a sample of German long-term (>6 months) travelers, 34% 
report being concerned about STIs or unintended pregnancy.108 
 Substance use during travel has received considerable attention in studies 
examining leisure/holiday travel and, increasingly, US study-abroad participants. Two 
longitudinal studies observe significant increases in US college students’ drinking 
behavior from the pre-travel to travel (study abroad) period.134,135 In another study, 
female students report their experience with alcohol-related sexual consequences during 
their semester abroad, including: “Has drinking gotten you into sexual situations you later 
regretted?” (23%) and “Because you had been drinking, have you neglected to use birth 
control or neglected to protect yourself from STIs?” (9%). In multivariable analysis, the 
number of alcohol-related sexual consequences was independently associated with: the 
number of drinks consumed per occasion, pre-departure expectations of drinking during 
travel, and experiencing culture-related social anxiety while abroad.135  
 Summary and gaps in understanding. The existing literature on travelers’ SRH 
is moderately sized but leaves many gaps. Women from the United States are the focus of 
only one study; findings from countries with different norms, policies, and approaches to 
SRH counseling may not be generalizable to US women. The abundance of clinic-based 
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samples leaves the experiences of many other travelers unrepresented. We cannot find 
any empirical evaluations of travelers’ use of contraception, other than condoms, and 
only one very small study reports findings for unintended pregnancy. Indeed, most of the 
studies are motivated by infectious health threats and therefore emphasize STIs and their 
antecedent behaviors more than other facets of SRH. Methodological limitations include 
invalid reference groups, lengthy recall periods, not adjusting for confounders, and 
pooling data from men and women in multivariable analyses. The fundamental question 
of whether travel itself is a risk factor for adverse SRH, versus the selection into 
international travel by “high-risk” people, remains essentially unanswered. 
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Chapter 2 
 
  The International Travel and Reproductive Health Study 
 
I. Study Design 
 
A. Overview 
 The data for this dissertation come from a mixed methods study of our own 
design, which was conducted at the University of Minnesota from 2015 to 2017. The 
quantitative portion of the study is comprised of cross-sectional, online surveys 
administered to two samples of female students: (1) Women who completed an 
international trip in the past three months (“Travelers”) and (2) Women who anticipate 
international travel in the next three months (“Pre-Travelers”). In the qualitative 
component of the study, we conducted semi-structured, in-depth interviews with female 
students, again recruiting two samples: Travelers and Pre-Travelers. Below, we outline 
our rationale for this methodological approach and describe the setting for our study. 
 
B. Rationale for mixed methods design 
 Epidemiologists are increasingly combining qualitative and quantitative research 
methods to answer questions about human health. This practice, termed mixed methods 
research, is applied to phenomena for which quantitative or qualitative methods are not 
sufficient on their own. Mixed methods research is implemented in myriad ways and 
there is no definitive text on its practice. However, the Office of Behavioral and Social 
Science Research (OBSSR) at the National Institutes of Health suggests some best 
practices for mixed methods research in the health sciences.136  
 In their guidelines, the OBSSR makes the following contrast: “Quantitative 
(mainly deductive) methods are ideal for measuring pervasiveness of ‘known’ 
phenomena and central patterns of association, including inferences of causality. 
Qualitative (mainly inductive) methods allow for identification of previously unknown 
processes, explanations of why and how phenomena occur, and the range of their 
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effects.”136 In our study, we used quantitative survey methods to examine known 
phenomena—new sexual partnerships and contraceptive use—in a novel setting: 
international travel. At the same time, we recognized the dearth of knowledge pertaining 
to the “why” and “how” of women’s SRH risks during travel. For example, how are risk 
(and protective) mechanisms activated during international travel? How do new cultural 
environments influence women’s SRH attitudes and behaviors? Why do some women 
anticipate having new sexual relationships while others do not? Qualitative methods 
allowed us to explore such questions in depth so that we could gain a holistic view of 
travelers’ SRH. Indeed, according to the OBSSR mixed methods research is often done to 
“develop a more complete understanding of a problem.”136 We chose a convergent 
(concurrent) mixed methods design, implementing the qualitative and quantitative study 
activities alongside one another.  
 
C. Rationale for cross-sectional design 
Our interest in phenomena that span the pre-travel and travel periods led us to 
consider a longitudinal design—i.e., sampling participants before their departure and 
following them prospectively. Instead, we chose a cross-sectional study for 
methodological reasons. We were concerned that asking women about their travel 
expectations and preparations before their departure would prime them to modify their 
travel behaviors. As previously noted, existing literature suggests that female travelers 
may be prone to unexpected sexual encounters, with implications for their contraceptive 
use (or lack thereof). A cross-sectional design allowed us to examine women’s SRH 
during travel absent these intervention-like effects. Additionally, the Pre-Traveler 
samples offered the opportunity to measure women’s travel preparations and expectations 
in real time, before these constructs were affected by non-differential recall or recall bias.  
 In the survey, Pre-Travelers also served as a counterfactual substitute for 
Travelers. It is possible that “high-risk” women select into international travel and that 
their baseline risk profile, not the travel context, is what drives their SRH risk. Our 
inclusion of a Pre-Traveler reference group, whom we sampled to resemble Travelers in 
terms of baseline characteristics, allows us to evaluate whether international travel itself 
is associated with increased SRH risks among young women. 
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D. Setting 
 Our study took place at the University of Minnesota-Twin Cities (UMN-TC) 
campus, which is home to some 30,500 undergraduate students and 16,300 graduate and 
professional students.137 Boynton Health Service (BHS), the on-campus clinic, conducts 
annual student surveys to monitor key indices of health, including sexual health. In the 
2015 survey, 75% of female UMN-TC students reported being sexually active in their 
lifetime and 70% within the past 12 months.138 Among students with lifetime sexual 
experience, the most commonly reported contraceptive methods used at last sex were: 
pills (44%), condoms (43%), and withdrawal (16%). (Students could report using 
multiple methods.) Other methods were reported by <10% of respondents. Nearly 1 in 6 
(16%) sexually active women used EC in the past year, 42% of them more than once. 
 International travel is popular among UMN-TC students. Over 2,600 studied 
abroad for academic credit in the 2013-2014 academic year—the sixth highest number 
among institutions nationwide. For some students, such as undergraduate management 
majors, international experiences are a requirement of their academic program. UMN-TC 
students also travel for non-university purposes such as leisure and volunteerism. Data on 
these types of travel are hard to find because there is no system for monitoring them.  
 On-campus resources for student travelers include the BHS and the Learning 
Abroad Center (LAC). BHS’ International Travel Clinic provides healthcare services for 
students and other travelers based on anticipated risks in their travel destination. From 
March 2014 to February 2015, the clinic served 465 female students plus additional 
students on the graduate insurance plan.139 BHS has no protocol in place for SRH 
counseling during travel medicine visits. The LAC oversees 300 international programs 
that UMN-TC undergraduate students complete for academic study, service learning, 
research, work, intern, and volunteer experiences. The graduate and professional schools 
administer their own international programs, where such programs exist. 
 
II. Study Procedures 
 
A. Research approvals 
 28 
 Our study protocol was reviewed and approved by the UMN-TC’s Institutional 
Review Board (#1506P73421), the BHS’s Research Committee, and the LAC. 
 
B. Recruitment 
 Eligibility criteria. Core inclusion criteria for the surveys and interviews were: 
female, 18-29 years old, UMN-TC student, has ever had sex with men, understands 
English, and considers the United States their home country (Table 6). Women with 
female sex partners were eligible if they also had male partners. We limited participation 
to students who call the United States “home” to avoid sampling international students 
traveling back to their native countries. While this phenomenon may carry its own 
significance for SRH, our study hypotheses implicate novel and unfamiliar travel 
settings. 
Samples were further delineated by travel and clinic status. First, Travelers (both 
survey and interview participants) reported an international trip in the past three months 
and Pre-Travelers expected travel in the next three months. To reduce the influence of 
recent travel experiences, the latter sample was also restricted to women without travel in 
the past six months. Second, all interviewees had completed at least one visit to a travel 
medicine clinic for their recent or upcoming trip.  
Table 6: Study eligibility criteria and recruitment strategies 
Inclusion criteria Exclusion criteria Recruitment strategies 
 
• Female 
• 18-29 years old 
• UMN-TC student 
• History of male sex partners 
• Understands English 
• Considers United States home 
• Interview: Completed travel 
medicine visit 
• Traveler: Completed international 
travel in past 3 months 
• Pre-Traveler: Intends international 
travel in next 3 months  
 
 
• Married 
• Engaged 
• Pregnant 
• Attempting pregnancy 
• Sterile 
• Pre-Traveler: 
International travel in 
past 6 months 
 
 
• Campus flyers 
• LAC e-mails to study 
abroad participants 
• Flyers in BHS travel 
medicine visits 
• Facebook 
• Interview: Snowball 
sampling  
BHS=Boynton Health Service, LAC=Learning Abroad Center 
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 To recruit a sample at risk of unintended pregnancy, we excluded from all 
samples women who were married, engaged, pregnant, attempting pregnancy, or sterile. 
As an exception, women who were pregnant at the time of screening, and who otherwise 
met Travel criteria, were eligible for the study so long as they were not pregnant when 
they began their trip. Becoming pregnant during international travel, especially 
unintentionally, is a salient (albeit rare) event that we wanted to capture. 
Eligibility screening. Potential participants self-screened for eligibility on the 
study website (z.umn.edu/TravelStudy). Based on participants’ responses, the website 
lists the activit(ies) for which they are eligible, if any, and asked them to check the ones 
in which they were interested. Participants could complete both the survey and interview 
if they were dually eligible, but only as a Traveler or Pre-Traveler. Also, participants 
could only complete each study activity once. 
Recruitment strategies. We recruited study participants through multiple modes 
(Table 6). Key recruitment partners were the LAC and BHS. The LAC announced our 
study in e-mails to groups of students registered for upcoming or recent study-abroad 
programs. The first wave of emails occurred in March 2016 and were repeated through 
March 2017. BHS distributed study flyers to female students during their travel medicine 
visits. Together, these targeted approaches to students with known travel histories or 
intentions allowed us to reach a high proportion of eligible participants. We also posted 
hundreds of flyers throughout campus. Lastly, we used snowball sampling by asking 
interview participants to refer friends or fellow students who may be eligible. 
 
C. Survey procedures 
Technology infrastructure. Our survey was designed and administered using 
REDCap, a secure, web-based data collection system developed at Vanderbilt University 
(project-redcap.org). REDCap is now used by a consortium of over 1,700 institutions, 
including the UMN-TC. With support from the University’s Clinical and Translational 
Science Institute, REDCap is offered to UMN-TC researchers free of charge and with 
dedicated technical support throughout the survey design and implementation phases. 
REDCap’s design features include multiple question and response types (e.g., multiple 
choice, matrix, slider bar), branching logic to skip questions, piping, calculated fields, 
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data validation, longitudinal surveys, and automated survey invitations and reminders. 
The security features of REDCap are equally robust: investigators can designate different 
levels of access to each project staff; data are backed up nightly on secure servers; and 
users can designate identifying fields to be excluded from data downloads.    
 Definition of reference periods. Our goal to compare travelers’ SRH outcomes to 
those of their non-traveling counterparts required us to consider how to best represent the 
counterfactual ideal in our survey design. One important component of the counterfactual 
was time: travelers’ outcomes occur in a chronological window defined by their departure 
and return dates. The probability of SRH events likely accumulates with the amount of 
time travelers spend in their destination; thus, it was important that we addressed time 
when choosing the reference period for which Pre-Travelers reported their recent U.S. 
behaviors. To mimic the natural variation in reference period duration among Travelers 
(i.e., trip length), we asked Pre-Travelers identical questions, but for a single reference 
period in the U.S.: 7 days, 14 days, 60 days, 3 months, 6 months, or 12 months. 
 Survey development. We aimed to develop a survey instrument that offered 
breadth of content, methodological rigor, and ease of use. For content, we operationalized 
variables in Tables 2 and 3 that could be measured with reliability and validity at the 
individual level. We also included measures to describe our study sample and control for 
confounding in analysis. We used existing measures from the literature, including 
previously validated instruments, whenever possible. We designed the survey to take no 
longer than 20 minutes to complete in order to limit the burden on survey respondents, 
thus optimizing data quality. The student PI and study research assistants (RAs) reviewed 
multiple survey drafts to make sure the questions were free typographical and 
grammatical errors, were organized in a logical order, and branched correctly based on 
responses to previous questions.   
 Pilot testing. The draft survey was pilot tested with 20 participants: 10 Travelers 
and 10 Pre-Travelers. Participants self-screened online for eligibility using the same 
criteria for the main study (Table 6). The study sessions were completed in person with 
study staff in private rooms on the UMN-TC campus. After providing their informed 
consent, participants were instructed to take the draft survey online in REDCap, taking 
note of any places where they were confused or the survey lacked flow. After they were 
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finished, staff led a 10-15 minute debrief session on the participants’ survey experience 
using a structured question guide (Appendix A). Questions probed survey items that 
were particularly uncomfortable or embarrassing; in need of editing or revision; or 
worked well. We also asked participants about the breadth, length, and overall survey 
experience. They received a $15 Amazon.com gift code in reimbursement of their effort. 
 Participants’ feedback on the draft survey was generally positive. Almost all said 
the survey was comprehensive in content but not too long. The handful of participants 
who took the draft survey on a tablet did not think that platform was ideal. Based on the 
input we received, we made minor adjustments to some survey items and response sets; 
added some new questions; broke up the survey into shorter pages; and added a note 
indicating that the survey is best viewed on a laptop or desktop computer.  
 Survey measures. Measures were distributed across five domains (Table 7):  
1) Baseline characteristics; 
2) SRH history; 
3) Pre-travel variables; 
4) Trip characteristics and experiences; and 
5) SRH during the reference period; 
 The survey was comprised mostly of objective, single-item measures and 
garnered high face validity with pilot study participants. However, we developed some of 
the measures expressly for this study and did not formally evaluate their psychometric 
properties. These include measures of language barriers and perceived accessibility of 
local SRH services (Domain 4). Other measures come from previously developed 
instruments. We measure the personality trait of sensation seeking (Domain 1) using the 
8-item Brief Sensation Seeking Scale (BSSS).140 The BSSS has exhibited adequate 
internal consistency (α=0.81 to 0.82) in samples of US college students.141,142 One of the 
most consistent pieces of feedback in our pilot study pertained to the first item in the 
BSSS: “I would like to explore strange places.” Many participants thought “strange” to 
be confusing or derisive; therefore, we altered this item to read, “…exotic or strange 
places.” All other items were retained in their original format. Measures for religiosity 
(Domain 1) were adapted from the National Survey of Family Growth.143   
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Table 7. Description of survey measures 
Measure Response set 
Domain 1: Baseline characteristics 
Age Years: Numeric (18 to 29) 
Student status Undergraduate or graduate/professional 
Race/ethnicity Check all: American Indian, Asian/Pacific Islander, Black/African American, 
Hispanic/Latina, White/Caucasian, other (specify) 
Religious denomination None, Catholic, Jewish, Protestant, other (specify)  
Importance of religion in daily life143 Likert: Not important (1) to very important (3) 
Sexual orientation Heterosexual/straight, gay/lesbian, bisexual, other (specify)  
Sensation-seeking; 8 items140  Likert: Strongly disagree (1) to strongly agree (5) 
Chronic condition requiring medication Yes, no 
Number of prior international trips 0, 1, 2-5, 6-10, more than 10 
Domain 2: SRH history 
Age at first sex Years: >13, numeric (13 to 25), >25 
Lifetime sex partners (male) Numeric up to “10 or more” 
Lifetime sex partners (female) Numeric up to “10 or more” 
Ever pregnant Yes, No, Unsure 
Pregnancies Numeric up to “5 or more” 
Abortions Numeric up to “5 or more” 
Births Numeric up to “5 or more” 
Has regular SRH care provider Yes, no 
STI diagnoses from healthcare provider Check all: Chlamydia, gonorrhea, HIV, syphilis, HPV/warts, herpes, pelvic inflammatory 
disease, not sure, other (specify), none of the above 
Ever-use of contraceptive methods Check all: Condom, pill, patch, ring, injectable, implant, IUD, withdrawal, natural family 
planning, diaphragm/cap, spermicide, EC, other (specify)  
Domain 3: Pre-travel variables 
Expectation to have sex Likert: Definitely not (1) to definitely (5) 
Expectation to meet a new sex partner Likert: Definitely not (1) to definitely (5) 
Received pre-travel health care  Yes, no 
Clinic type  Check all: Travel, primary care, other (specify) 
Clinic site  Boynton, other 
Services received  Check all: Vaccinations, physical exam, prescription refill, anti-malarials, prophylactic 
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Table 7. Description of survey measures 
Measure Response set 
antibiotics, birth control, pregnancy test, counseling, other (specify) 
Domain 4: Trip characteristics and experiences  
Destination countr(ies) Open text 
Trip duration Departure and return dates 
Purpose (primary) Study abroad, other academic, conference, work, volunteer, leisure, other (specify) 
Travel companions Check all: Friend, family, romantic partner, students, guide/translator, supervisor, 
professor, study abroad staff, other (specify) 
Type of residence  Check all: Hotel/resort, hostel, apartment/house, host family residence, friend/family 
residence, other (specify) 
Travelers only: 
Carried travel health insurance  
 
Yes, no, unsure 
Language barriers: Perceived frequency  Likert: Never (1) to always (5) 
Language barriers: Perceived impact  Likert: Not at all (1) to a great extent (4) 
Alcoholic drinks per week (average) Number  
Binge drinking Yes, no 
Used any recreational drugs Yes, no 
Perceived accessibility of local SRH services Likert: Very difficult (1) to very easy (5) 
Domain 5: SRH during the reference perioda 
Relationship status Single, casual/dating, serious relationship 
Had sex Yes, no 
Gender of sex partner(s) Check all: Male, female 
Male sex partners Number up to “5 or more” 
Relationship with male partner(s) Check all: Boyfriend/partner, friend, casual/stranger, local resident,b traveler from another 
country,b other (specify) 
Had new partner(s) Yes, no 
Had unexpected sex Yes, no 
Contraceptive method(s) used Check all: Condom, pill, patch, ring, injectable, implant, IUD, withdrawal, natural family 
planning, diaphragm/cap, spermicide, EC, abstinence, other (specify) 
Satisfaction with contraception Likert: Very unsatisfied (1) to very satisfied (4) 
Contraceptive lapses (21 items)c Yes, no 
Started a new contraceptive method Yes, no 
Switched contraceptive methods Yes, no 
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Table 7. Description of survey measures 
Measure Response set 
Didn’t have contraception on hand when needed Yes, No 
Had trouble finding contraception Yes, no 
Contraception lost or stolen Yes, no 
Got off schedule with contraception due to travel 
across time zones  
Yes, no 
Had sex without any contraception Yes, no 
Had trouble communicating with a sex partner 
about using contraception 
Yes, no 
Frequency of condom use during sex Likert: None of the time (1) to all of the time (4) 
 
Travelers only: 
Brought condoms 
 
 
Yes, no 
Brought contraception  Yes, no 
Brought emergency contraception Yes, no 
Got pregnant Yes, no 
Got an STI Yes, no 
aRefers to index trip (Travelers) or recent period in the U.S. (Pre-Travelers). bResponse options for Travelers only. cSee Table 8 for full description of 
contraceptive lapse measures. EC=emergency contraception, HPV=human papillomavirus, IUD=intrauterine device, SRH=sexual and reproductive health, 
STI=sexually transmitted infection. 
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Data collection. Participants who screened eligible and interested received an e-
mail invitation from REDCap with a unique survey link. The IRB-approved consent form 
was integrated directly into the survey interface as the first question. Participants could 
stop the survey and return later with a unique access code. Only one survey question, 
travel destination (country or countries) was required because its value was piped into 
many subsequent questions. Participants received a $10 Amazon.com gift code within 48 
hours of their completing the survey. 
 Using the last digit of Pre-Travelers’ system-generated study ID number, 
REDCap sorted them into a single survey reference period: 1 = 7 days; 2 or 3 = 14 days; 
4 or 5 = 60 days, 6 or 7 = 3 months, 8 or 9 = 6 months, and 0 = 12 months. We assigned 
participants to the 7-day and 12-month modules at half the frequency of the others 
because we did not expect as many trips at these extreme durations. It was not feasible 
for us to implement a truly random allocation process in REDCap; however, we believe 
this process to be unbiased because it was simply determined by the order in which 
participants screened online for eligibility.  
  
D. Qualitative interview procedures 
Qualitative interview guides and measures. We used semi-structured interview 
guides, one for Pre-Travelers and one for Travelers. A semi-structured format afforded 
consistency across interview sessions, but also flexibility in how deeply each question 
was explored during a given session. As with the survey, our aim was to cover multiple 
facets of the travel/SRH phenomenon in an acceptable time frame (here, less than 60 
minutes). The interview questions (Appendices B and C) assessed a variety of topics 
under the following categories: pre-travel expectations, concerns, and preparations; 
general trip information; SRH concerns and experiences during travel; experiences and 
attitudes related to their travel medicine visit; advice for other travelers; and lifetime 
SRH-related travel experiences. Only some of these measures were analyzed for this 
dissertation. More details about those measures and the development of the qualitative 
interview guides are provided in Manuscript 3 (page 72).  
 Interviewer training. Interviews were conducted by the student principal 
investigator (PI) and two female RAs who were also MPH students in the University of 
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Minnesota School of Public Health. The student PI, who is experienced conducting 
qualitative interviews, trained the RAs for this study. Training activities included 
rehearsing the interview questions in role-play, direct observation of PI-led interviews, 
and conducting two interview sessions under supervision of the PI. After each RA 
independently completed her first interview, the PI reviewed the recording and gave 
feedback on successful techniques or areas for improvement.    
Data collection. Participants who screened eligible and interested in the 
qualitative interview were contacted by e-mail to schedule their session. Interview 
sessions were completed in person, in a private space, and at the participants’ preferred 
location (West Bank, East Bank, or St. Paul campus). We began the session with the 
informed consent process then distributed a brief self-administered baseline questionnaire 
assessing baseline characteristics, SRH history, and trip information. We then proceeded 
with the interview, which was digitally recorded. Upon completion of the interview, we 
reimbursed participants with a $20 Amazon.com gift code. 
 Post-interview data management. After the interview, data from baseline 
questionnaires were entered into REDCap. Interview recordings were copied into a 
private folder on the Division of Epidemiology & Community Health server and deleted 
from the recording device. We transcribed interviews verbatim into Microsoft Word files 
as soon as possible after the study session. Recollection of non-verbal events helped us 
note, for example, whether participants expressed themselves with sarcasm or 
emphasized a statement hand gestures. The student PI reviewed all transcriptions for 
completeness and accuracy, at which point the recordings were permanently deleted from 
the server. 
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Chapter 3 
 
Manuscript 1 
Risk of contraceptive lapse and new sexual partnership among female 
university students traveling internationally 
 
Introduction 
 
International travel is increasingly popular among United States residents, 
including among youth. US citizens took over 72 million trips outside the country in 
2016, an 8% increase over 2015.54 Participation in study abroad programs is also on the 
rise. In the 2014-15 academic year, 314,515 US students traveled abroad for academic 
credit, 3% more than in the previous year and 52% more than a decade ago.57  
 The sexual and reproductive health (SRH) risks of international travel have 
garnered increasing concern with the global spread of HIV, antibiotic-resistant sexually 
transmitted infections (STIs), and more recently, Zika virus.144 Many aspects of 
international travel may influence SRH—e.g., perceived anonymity, disruption of 
routines, new sexual networks, cultural norms, local laws, and access to local health care 
services. Existing studies of travelers’ SRH feature mostly clinic-based samples and are 
overwhelmingly focused on condom use, “casual” sex, and other STI risk behaviors.79,110 
In contrast, research into travelers’ contraceptive behaviors—the cornerstone of 
pregnancy prevention—is lacking. Literature comparing travelers with non-travelers is 
also sparse, making it unclear whether travel causes adverse SRH outcomes or if high-
risk individuals disproportionately engage in international travel.  
 Emerging adulthood is both a common time for international travel and a risky 
period for SRH, especially for women. Nearly 7 in 10 US women ages 15-24 who use 
contraception rely on either the pill or condom, methods that are highly error-prone.47,48 
Nationally, inconsistent contraception use accounts for 41% of unintended pregnancies 
and women ages 18-29 exhibit the highest unintended pregnancy rates.6,145 Early 
adulthood is also characterized by the formation of new sexual relationships, which 
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predict incident STIs in longitudinal studies of young women. 38,39 Furthermore, youth 
typically favor condoms over more effective contraceptive methods within new and less 
committed sexual partnerships.146 Thus, women’s efforts to protect themselves from STIs 
in new relationships may leave them more vulnerable to unintended pregnancy. 
In sum, young women face many SRH risks that may be exacerbated by the 
circumstances of foreign travel, yet few studies have examined this relationship. To 
address this knowledge gap, we conducted a cross-sectional study of women ages 18 to 
29 in order to evaluate international travel as a risk factor for two SRH outcomes: 
contraceptive lapse and new sexual partnerships. Our goal was to inform the counseling 
practices of clinicians, administrators, and other practitioners who interact with young 
women as they prepare for international travel. 
 
Methods 
 
We conducted a cross-sectional survey of female university students who recently 
traveled internationally (Travelers) or planned to travel in the near future (Pre-Travelers). 
Both samples reported on their SRH during a recent reference period: for Travelers, their 
international trip, and for Pre-Travelers, a period of similar duration prior to their 
upcoming trip. The latter group—women with a known propensity for international 
travel—was selected to represent the counterfactual experience of Travelers, had they 
stayed in the United States. That is, Pre-Travelers were assumed to be similar to 
Travelers with regard to risk behavior and other potential confounding variables. We 
chose a cross-sectional, rather than prospective, design to avoid priming of travel 
behaviors by pre-departure measures. The study protocol was approved by the University 
of Minnesota Institutional Review Board. 
 
Recruitment and Sample 
Participants were recruited from the Twin Cities campus of the University of 
Minnesota via flyers, Facebook, the campus study abroad office, and the campus travel 
clinic. Potential participants self-screened on the study website based on the following 
inclusion criteria: female, aged 18-29 years, history of sex with male partner(s), 
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understands English, and considers the United States their home country. Inclusion 
criteria were further delineated by travel status: Traveler (completed international travel 
in past 3 months) or Pre-Traveler (no international travel in past 6 months, but intends 
international travel in the next 3 months). We excluded women who did not meet the 
travel requirements and women who were married, engaged, pregnant, attempting 
pregnancy, or sterile, to focus on a target population of those at risk of unintended 
pregnancy and new sexual partnerships. After completing the screening questions, 
women were shown the survey for which they were eligible (if any)—Traveler or Pre-
Traveler—and asked to indicate their interest; participants could not screen eligible for 
both surveys. We recruited more Travelers than Pre-Travelers because of other study 
aims pertaining to outcomes among Travelers only. 
 
Survey Procedures 
Data were collected through an online survey designed and administered with 
REDCap electronic data capture tools hosted at the University of Minnesota.147 The 
survey was drafted and pilot-tested with 20 participants, 10 Travelers and 10 Pre-
Travelers, who met the eligibility criteria for the main study. After verbally consenting, 
participants completed the draft survey and provided feedback on its content (breadth, 
depth, sensitivity) and structure as well as the overall user experience. They were 
compensated with a $15 gift card. Pilot testing confirmed that the survey duration fell in 
our target range of 15-20 minutes. Minor modifications were made before fielding the 
final survey. Data from pilot surveys were not included in this analysis.  
Survey data were collected from February 2016 to March 2017. Participants who 
screened eligible and interested were e-mailed a unique link to the REDCap survey and 
one reminder if the survey remained incomplete after seven days. A consent form was 
integrated as the first survey question. Participants were e-mailed a $10 electronic gift 
card upon completing the survey.  
Nearly 1,400 women screened for the study (not including pilot study 
participants), of whom 584 were eligible (Figure 1). After excluding women who 
declined to participate (n=19) or did not submit a complete survey response (n=54), as 
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well as one Pre-Traveler who took the survey after her trip, we had 340 Travelers and 
170 Pre-Travelers available for analysis. 
 
Measures 
Participants reported information for study outcomes and several other covariates 
relative to a reference period. This period varied in duration both between and within the 
two samples. For Travelers, it corresponded to their most recent international trip and 
therefore depended on each traveler’s departure and return dates. Because we expected 
reference period duration to be associated with SRH outcomes, we induced variation in 
the Pre-Traveler sample with a REDCap algorithm that assigned each participant to a 
single reference period: 7 days, 14 days, 30 days, 60 days, 3 months, 6 months, or 12 
months. Thus, all Pre-Travelers responded to the same questions, but relative to their 
assigned reference period. 
All outcome measures pertained to sexual activity and contraceptive use in the 
reference period. Participants were asked whether they had sex and, if so, the gender of 
their sex partner(s) and whether any male partners were new (“someone you had not had 
sex with before”). Responses to the last question comprised our dichotomous outcome 
variable indicating a new sexual partnership. Participants selected from a checklist the 
contraceptive methods they used at any point during the reference period and, for each 
method, were branched to follow-up questions gauging method-specific errors and 
adherence. We used these data to derive a dichotomous outcome variable for 
contraceptive lapse, as described in Table 8.  
For each participant, we first coded lapse at the method level and then aggregated 
across all her reported methods (except condoms and withdrawal) such that any lapse 
constituted a lapse for the outcome variable. Our approach for condoms and withdrawal 
recognized the frequency with which these methods are backed up by other forms of 
contraception in the same act of intercourse (“dual method use”)148,149. In our data, we 
could not determine whether the reporting of multiple methods represented dual method 
use because we did not assess women’s contraceptive use at each coital event. However, 
we collected limited data on method type for participants’ last intercourse and found that 
over 50% of women who used condoms or withdrawal did so in conjunction with other 
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methods. Therefore, to reduce the influence of dual method use on our outcome variable 
we only counted lapses on condoms or withdrawal among exclusive users—women who 
didn’t use any other contraception during the reference period.  
For non sex-dependent methods (Table 8), we coded lapse regardless of whether 
users were sexually active during the reference period. Sex does not carry risk of 
pregnancy on the day of a hormonal method lapse, but rather some days later when 
physiologic responses to lapse (i.e., follicular development, ovulation, and changes in 
cervical mucus) potentially manifest.150 A lapse on hormonal contraception is therefore 
an inherently risky behavior, as it requires a commitment to future abstinence that may 
not be upheld.   
We measured additional baseline variables to describe our study population and 
adjust for potential confounding. Demographic characteristics included age, student 
status (undergraduate or graduate), race/ethnicity, religious denomination, religiosity, and 
sexual orientation. We asked participants whether they had a regular SRH care provider 
or had a chronic health condition requiring ongoing prescription medication. Measures of 
SRH history consisted of age at sexual debut, number and gender of lifetime sexual 
partners, emergency contraception (EC) use, and history of pregnancy or STI diagnosis. 
Participants also reported their number of lifetime international trips. We incorporated the 
Brief Sensation Seeking Scale (BSSS),140 an 8-item instrument that has exhibited internal 
consistency (α=0.81 to 0.82) in samples of US college students.142,151 Sensation seeking, 
a personality trait denoting an attraction to novel sensations and experiences such as 
international travel, is associated with high-risk sexual behaviors.152 Respondents 
indicated their agreement with each BSSS item (e.g., “I get restless when I spend too 
much time at home.”) on a 5-point Likert scale. A summary score was calculated as the 
mean of the eight items, per instructions from the instrument’s authors. Higher scores 
represented higher sensation seeking.   
   
Analysis 
We estimated relative risks of contraceptive lapse and new sexual partnership by 
travel status using multivariable modified Poisson regression models with robust standard 
errors.153 Although our study was designed to minimize confounding by comparing 
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similar groups of women, we also assessed confounding empirically. We considered 
covariates that we specified a priori to be potentially associated with either contraceptive 
lapse or new sexual partnership, and that may also be related travel status: baseline 
variables (demographic characteristics, sensation seeking, having a regular SRH care 
provider, having a chronic health condition requiring ongoing medication, age at sexual 
debut, number of lifetime sex partners, history of female sex partners, sexual orientation, 
and history of pregnancy, STIs, EC use, or international travel), reference period 
duration, and type of contraceptive method(s) used during the reference period. We 
conducted bivariate analyses to empirically identify which variables were differentially 
distributed by travel status and each outcome variable using the chi-squared statistic or 
Fisher’s exact test (for categorical variables) and t-test or Wilcoxon rank-sum test (for 
continuous variables). For each outcome, variables associated with both exposure and 
outcome at p<.10 were entered into a multivariable model along with travel status. 
Regression analyses were conducted on complete cases given the low percentage of 
observations with missing data (0.8% to 3.2% by model). We performed all analyses 
using StataSE version 14.2 (StataCorp; College Station, Texas). 
During analysis, we discovered that a higher proportion of Travelers than Pre-
Travelers was sexually active during the reference period. We considered sex to be a 
consequence of travel status and, accordingly, did not adjust for it in multivariable 
analysis. However, we ran a supplemental model for new sexual partnership that was 
restricted to participants who were sexually active during the reference period to compare 
groups with similar probabilities of sex.   
We powered our study for new sexual partnership, one of the few SRH outcomes 
reported for female travelers in the extant literature.79 We planned to enroll 375 Travelers 
and 125 Pre-Travelers, but adjusted our enrollment targets during data collection in order 
to recruit more quickly. Our revised sample sizes yielded 84% power to detect a new 
partnership prevalence of 20% (Travelers, n=340) vs. 10% (Pre-Travelers, n=170).  
 
Results 
 
 43 
Most participants were undergraduate students (86.8%), were white/non-Hispanic 
(83.9%), had a regular source of SRH care (80.1%), and had travelled internationally at 
some point before the reference period (88.8%) (Table 9). Prior pregnancy or STI were 
reported very infrequently (<6%) in both Travelers and Pre-Travelers. The two groups 
were generally comparable on baseline characteristics, but some differences were 
statistically significant at our threshold of p<10. Compared with Pre-Travelers, Travelers 
were slightly older (mean=21.1 years vs. 20.4 years), less likely to be undergraduate 
students (84.6% vs. 91.1%), more sensation seeking (mean=3.46 vs. 3.32), less likely to 
identify as heterosexual (82.9% vs. 90.0%), and were more likely to have ever used EC 
(45.3% vs. 35.9%). Among Travelers (data not shown in table), the most common 
destinations were Europe (40.3%) and Central or South America (18.5%); 48.2% traveled 
for academic purposes, 42.4% for leisure, and 9.4% for work or volunteerism. Forty-two 
percent of Travelers saw a healthcare provider in preparation for their trip and 21.5% 
received care at a travel medicine clinic, specifically. 
The crude prevalence of contraceptive lapse during the reference period (Table 
10) was similar for Travelers (29.1%) and Pre-Travelers (31.8%), including among 
participants who were sexually active during the reference period (31.5% and 35.1%, 
respectively). New sexual partnerships with men were more common among Travelers 
(17.4% vs. 11.8%; p=0.10) even though Travelers were less likely to have sex (31.8% vs. 
65.3%; p< .0001). Among participants who had sex, new male partners were reported 
three times more frequently by Travelers (54.6% vs. 18.0%, p<.0001).  
The most commonly reported contraceptive method was the pill. Pill use was 
higher among Pre-Travelers than Travelers (62.9% vs. 50.0%; p=.006), but both groups 
were equally likely to report a pill lapse (49.5% vs. 50.0%, respectively; data not shown 
in table). Pre-Travelers were significantly more likely to report using condoms and 
withdrawal. Multiple contraceptive methods were reported by 28.2% (n=144), almost 
entirely involving use of condoms (n=81), withdrawal (n=25), or both methods (n=34). 
Only 0.8% (n=4) of the sample reported multiple methods that did not include condoms 
or withdrawal. 
After adjusting for confounders (Table 11), we found no association between 
travel and contraceptive lapse (aRR=1.05; 95% CI, 0.83—1.32). However, risk of new 
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sexual partnership was 70% higher among Travelers than Pre-Travelers in the full sample 
(aRR=1.71; 95% CI, 1.07—2.74) and nearly three times higher when the sample was 
restricted to participants who had sex with men during the reference period (aRR=2.82; 
95% CI, 1.89—4.21). 
 
Discussion 
 
We found evidence for increased risk of new sexual partnership, but not 
contraceptive lapse, during young women’s international travel. To our knowledge, this 
study is the first to examine travel as an independent risk factor for these outcomes 
among women by comparing travelers with non-travelers. Without an appropriate 
comparison group, previous studies could not determine whether the SRH outcomes 
observed for travelers are attributable to travel itself or to selection into travel by 
sensation-seeking individuals predisposed to sexual risk-taking. Isolating the effect of 
travel is an important contribution, as it suggests distinct avenues for intervention.  
Women frequently engage in international travel—approximately 36 million US 
women in 201656—yet the contraceptive behaviors of female travelers are virtually 
unexplored in the research literature. Certain aspects of international travel may make 
contraceptive lapse not only more likely, but also more consequential. In the aftermath of 
a lapse, travelers may need access to clinical services—e.g., EC, STI testing and 
abortion—that are inaccessible or unsafe in the local destination. For brief trips, the 
ramifications of contraceptive lapse may surface after women return home but are 
nonetheless significant.   
Nearly one-third of the international travelers in our study experienced a 
contraceptive lapse, a proportion similar to what we observed in non-travelers. Our null 
findings may indicate a lack of travel-specific risk mechanisms, but may also mask 
heterogeneity in the effects of travel. For example, certain types of trips (e.g., academic, 
leisure, solo or accompanied) may affect women’s contraceptive behaviors more than 
others; this warrants exploration in future research. Our focus on university students, half 
of whom were using the pill, could also have influenced our results. Student life and 
international travel both favor factors contributing to pill lapse—e.g., disrupted routines, 
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fatigue, and perceived stress related to school or work 154,155—thereby reducing the 
relative impact of travel on women’s behavior. 
We found a 70% increased likelihood of new male sexual partners associated with 
international travel. The significance of this finding is two-fold. First, women use less 
effective methods of contraception in both new and casual relationships, which increases 
their risk of unintended pregnancy.146 Second, open communication between sexual 
partners facilitates many positive SRH outcomes 156 and new relationships are 
characterized by non-verbal, indirect, and ambiguous communication.157 Partnerships 
initiated during international travel may also be encumbered by linguistic and cultural 
differences, further increasing women’s susceptibility to pregnancy and STIs.  
Some previous studies, while not directly comparable to ours, offer insight into 
our findings for new sexual partnerships. Sundbeck et al. used a case-crossover design to 
estimate risk of having a casual male sex partner (defined as previous partner, friend, 
casual contact, commercial sex partner, or another non-regular partner) during 
international travel, compared to at home, in a population-based sample of young 
Swedish women.120 Their analysis only considered participants’ most recent sexual 
encounters in the past 12 months (at home and abroad, respectively) and did not precisely 
account for trip duration. They reported a five-fold increased risk of casual sex associated 
with international travel (incidence rate ratio [IRR] 5.31, 95%CI 4.27—6.60). Another 
prospective study of 427 university students in the U.K. more resembles our study 
population, but does not provide estimates specific to women. Male and female students 
who traveled abroad over their summer break were more likely to report new sexual 
partners (aRR 2.46, 95% CI 1.01–6.06) than those who stayed in the U.K.121 Whether 
women are more likely to establish new sexual partnerships when they travel 
internationally, as we found in our study, should be examined in more studies that make 
valid comparisons between travelers and non-travelers.  
In addition to being one of the few comparative studies on SRH related to travel, 
our study provides novel estimates for the prevalence of new sexual partnerships among 
US women traveling abroad. Given the international variation in healthcare systems and 
our interest in providing guidance to US health care providers, this is a notable 
contribution. In prior studies, the frequency of new sexual partners among female 
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travelers has ranged widely from 2%93 to 62%101 depending on sampling venue and 
participant characteristics. Our finding for US women, 17.4%, is similar to the 19.5% 
prevalence pooled from 13 studies in a 2010 meta-analysis.79 Our study further 
contributes to this evidence base with a sample that is not exclusively clinic-based and is 
heterogeneous with respect to trip purpose, destination and duration. Most studies have 
recruited attendees of STI or travel clinics (e.g., 92), residents of hostels (e.g., 106), or 
women traveling to high-risk destinations (e.g., 89), all of which are select populations 
and may differ substantially from the broader traveling population.  
Our study has additional methodological strengths. We compared travelers with 
non-travelers while avoiding the pitfalls of priming and biased recall of pre-travel 
behaviors. This approach was taken to minimize confounding at the design stage; we 
further addressed potential confounding through the collection of a rich set of covariates 
known to be associated with SRH behaviors. Our survey also garnered a high 88% 
(511/584) response rate among eligibles and very low rates of missing data at the variable 
level.  
There are also limitations to our study. First, recall of events that occurred as long 
as one year before the survey may have been inaccurate. Some literature indicates 
favorable test-retest reliability for SRH measures up to six months, although findings are 
very mixed by type of measure and study population.158-161 Recall may have also been 
differential by exposure status if travelers had more salient experiences to aid their 
recollections, thus introducing bias. Second, we chose a dichotomous measure of 
contraceptive lapse that did not capture severity or frequency of lapse, variables that are 
more proximal to pregnancy risk. Third, for women who reported multiple contraceptive 
methods, we could not differentiate concurrent from discrete method use. Our outcome 
variable did not include condom and withdrawal lapses that occurred among these 
women; thus, we may have underestimated the true prevalence of contraceptive lapse. 
Fourth, our self-reported measures were susceptible to social desirability bias, although 
web-based surveys are the ideal mode for eliciting sensitive information.162 Lastly, our 
sample was comprised of women enrolled in a public university and their experiences 
may not be representative of the population of female travelers at large. 
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While our findings should be corroborated by additional research, they suggest a 
potential role for healthcare providers in the pre-travel period. About 80% of the women 
in our study had a regular SRH care provider and 42% of travelers sought care from a 
clinic in preparation for their trip. Clinicians of all specialties are in a unique position to 
counsel travelers on potential health risks. Counseling should address the possibility of 
new sexual partnerships during travel, travelers’ plans for pregnancy prevention, and 
what to do in the case of a contraceptive lapse or unintended pregnancy.
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Figure 1. Study flowchart 
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Table 8. Classification of contraceptive lapse by method type 
Methoda  Criteria for contraceptive lapse 
 
Not sex dependent 
Implant • Not applicableb 
  
Intrauterine device • Not applicableb 
  
Injectable • Missed or was >7 days late for injection. 
  
Pill • Missed (>24 hours late) one or more active pills. 
  
Patch • Changed a patch >24 hours past schedule or 
• Applied a new patch >24 hours past schedule. 
  
Ring • Removed a ring >24 hours past schedule; 
• Inserted a ring >24 hours past schedule; or 
• Left a ring out for >3 hours. 
 
Sex dependent 
Condomc Did not use any other method of contraception and: 
• Had a condom break or slip off during sex; 
• Started having sex before using a condom; 
• Took off a condom before sex was over; or 
• Had sex more than once with the same condom. 
  
Withdrawalc Did not use any other method of contraception and: 
• Had a partner who did not pull out in time. 
  
Natural family 
planning 
• Had sex on fertile days without using another method; or 
• Was sexually active and could not identify her fertile days with 
confidence. 
  
No method • Had sex with a male partner. 
aLapse was classified for all methods participants reported using for contraception, regardless of 
method effectiveness. bBehavioral lapse is not possible on this method. cLapse definition was 
restricted to exclusive users to rule out possibility of dual method use. 
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Table 9. Baseline participant characteristics by international travel status 
 Status  
  Traveler  
n (%) 
Pre-Traveler  
n (%) p-value
a 
    
Total 340 (100.0) 170 (100.0) -- 
    
Age at survey (years)      
     18-19 
     20-21 
     22-29 
 
69 (20.7) 
167 (50.2) 
97 (29.1) 
 
47 (27.7) 
98 (57.7) 
25 (14.7) 
 
.001 
Undergraduate student 286 (84.6) 154 (91.1) .04 
Race/ethnicity 
     Asian/Pacific Islander 
     White, non-Hispanic 
     Other 
 
25 (7.4) 
279 (82.1) 
36 (10.5) 
 
11 (6.5) 
149 (87.7) 
10 (5.9) 
 
.19 
Religion 
     Catholic 
     Protestant 
     Other 
     None 
 
77 (22.7) 
69 (20.3) 
32 (9.4) 
162 (47.7) 
 
31 (18.2) 
47 (27.7) 
14 (8.2) 
78 (45.9) 
 
.26 
Importance of religion in daily life 
     Not important 
     Somewhat important 
     Very important 
 
219 (64.6) 
87 (25.7) 
33 (9.7) 
 
100 (58.8) 
54 (31.8) 
16 (9.4) 
 
.34 
Sensation-seeking score,b mean±SD 3.46±0.6 3.32±0.7 .02 
Has a regular SRH care provider 277 (81.7) 129 (76.8) .19 
Has a chronic health condition requiring ongoing 
medication 
70 (20.6) 34 (20.0) .88 
Younger than 17 years old at sexual debut 48 (14.2) 16 (9.6) .12 
Number of lifetime male sexual partners 
     1 or 2 
     3 to 5 
     6 to 9 
     10 or more 
 
144 (42.4) 
91 (26.8) 
51 (15.0) 
54 (15.9) 
 
84 (49.4) 
50 (29.4) 
18 (10.6) 
18 (10.6) 
 
.14 
Sexual orientation 
     Heterosexual 
     Bisexual 
     Gay/lesbian/other 
 
282 (82.9) 
48 (14.1) 
10 (2.9) 
 
153 (90.0) 
13 (7.7) 
4 (2.4) 
 
.09 
History of female sex partners 38 (11.2) 12 (7.0) .14 
History of pregnancy 4 (1.2) 2 (1.2) 1.00 
History of STI diagnosis 21 (6.2) 8 (4.7) .50 
History of emergency contraception use 154 (45.3) 61 (35.9) .04 
History of international travelc 306 (90.0) 147 (86.5) .23 
Table entries are n(column %) unless otherwise specified. aP-values correspond to X2 statistic for categorical 
variables and t-test for continuous variables. bScores are means from 8-item scale with items scored from 1 
(low sensation-seeking) to 5 (high sensation-seeking). cDoes not include travel during the reference period. 
SD=standard deviation; STI=sexually transmitted infection. 
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Table 10. Bivariate comparisons of survey reference period variables by international 
travel status 
 Status  
 Traveler  
n (%) 
Pre-Traveler  
n (%) p-value
a 
    
Total 340 (100.0) 170 (100.0) -- 
    
Outcome variables    
Had a contraceptive lapse 99 (29.1) 54 (31.8) .54 
If sexually activeb                              
34 (31.5) 
                        
39 (35.1) 
.57 
Had sex with a new male partner 
If sexually activeb 
59 (17.4) 
59 (54.6) 
20 (11.8) 
20 (18.0) 
.10 
<.0001 
    
Other variables    
Had sex with male partner(s) 108 (31.8) 111 (65.3) <.0001 
Contraceptive method(s) used:c 
Implant 
Intrauterine device 
Injectable 
Pill  
Patch 
Ring 
Condom 
Withdrawal 
Natural family planning 
Emergency contraception 
 
14 (4.1) 
39 (11.5) 
4 (1.2) 
170 (50.0) 
3 (0.9) 
12 (3.5) 
67 (19.7) 
23 (6.8) 
3 (0.9) 
6 (1.8) 
 
10 (5.9) 
22 (12.9) 
1 (0.6) 
107 (62.9) 
1 (0.6) 
4 (2.4) 
71 (41.8) 
36 (21.2) 
2 (1.2) 
5 (2.9) 
 
.38 
.63 
.67 
.006 
1.00 
.47 
<.0001 
<.0001 
1.00 
.39 
Duration of reference period (days) 
Median 
Range 
 
18 
2 to 361 
 
30 
7 to 365 
 
<.001 
Table entries are n(column %) unless otherwise specified. aP-values correspond to the X2 statistic for 
categorical variables and Wilcoxon rank-sum test for continuous variables. bRefers to sex with male 
partner(s) during the reference period. cCategories are not mutually exclusive; participants could report 
using multiple methods during the reference period.  
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Table 11. Adjusted relative risk of contraceptive lapse or new sexual partnership 
associated with international travel 
 aRR 95% CI 
Model 1:  Contraceptive lapse (All participants; n=506) 
     Traveler 
     Pre-Traveler 
Model 2:  New sexual partnership (All participants; n=499) 
     Traveler 
     Pre-Traveler 
Model 3:  New sexual partnership (Sexually active participants;c 
n=212) 
     Traveler 
     Pre-Traveler 
 
1.05a 
1.0 (ref.) 
 
1.71b 
1.0 (ref.) 
 
2.82b 
1.0 (ref.) 
 
[0.83—1.32] 
 
 
[1.07—2.74] 
 
 
[1.89—4.21] 
aAdjusted for sensation-seeking score, duration of the reference period, and use of the pill during the 
reference period. bAdjusted for age category, sensation-seeking score, and duration of the reference 
period. cRefers to sex with male partner(s) during the reference period. 
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Chapter 4 
 
Manuscript 2 
Pregnancy prevention on the fly: Prevalence and correlates of 
contraceptive lapse among young women traveling internationally 
 
Introduction  
 
 Over the past 20 years, clinical guidelines for international travelers have 
increasingly emphasized the prevention of sexually transmitted infections (STIs) through 
safer sex counseling and vaccination.163 Unintended pregnancy, in contrast, garnered 
little attention as a travel health concern until the rapid spread of Zika virus.164 Similarly, 
the empirical literature concerning travelers’ sexual and reproductive health (SRH) is 
predominantly focused on STIs and related behaviors (e.g., new sexual partnerships, 
condom use). Most existing studies examine European and clinic-based samples, and few 
studies evaluate SRH risk factors specifically for female travelers.79 There is a 
conspicuous lack of research regarding women’s use of contraceptive methods, other than 
condoms, during international travel. 
 The contraceptive practices of female travelers are significant given both the 
popularity of international travel and the stubbornly high rates of unintended pregnancy 
among young women in the United States.6 Women account for half of the overseas trips 
taken by US residents,56 or roughly 36 million trips in 2016.54 Nationwide, 41% of 
unintended pregnancies are attributable to mis-use of contraception 145 and young women 
favor error-prone methods like pills and condoms.47,48 Women’s sexual behaviors, 
contraceptive behaviors, and pregnancy risk are shaped by a constellation of factors 
within physiological, psychosocial, structural, and cultural domains.34,49,165 We posit that 
these domains operate in unique ways during international travel (Table 12).  
 This study examines the prevalence and correlates of contraceptive lapse in a 
sample of female university students traveling internationally. Our aim was to identify 
potential opportunities for clinicians to mitigate the SRH risks of travel.  
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 Materials and Methods 
 
Recruitment and Sample 
 Our data come from the International Travel and Reproductive Health Study, a 
cross-sectional survey of female university students who either recently traveled outside 
the United States or planned to do so in the near future. This analysis is limited to the 
former group of recent travelers (n=340). We recruited participants from the University 
of Minnesota, Twin Cities campus through flyers, Facebook, the campus study abroad 
office, and the campus travel clinic. Recruitment materials directed potential participants 
to complete a brief screening survey on the study website. Inclusion criteria were: female, 
aged 18-29 years, history of sex with men, understands English, considers the United 
States their home country, and completed an international trip in the prior three months. 
Women were excluded if they were married, engaged, pregnant, attempting pregnancy, or 
sterile. If eligible, women were asked to indicate their interest in participating in a 15-20 
minute online survey about their SRH during their recent trip.  
 
Survey Procedures 
 The University of Minnesota Institutional Review Board approved the study 
protocol. The online survey was designed and administered using REDCap electronic 
data capture tools hosted at the University of Minnesota.147 We pilot tested a draft survey 
from October 2015 to January 2016 with 10 participants using the same eligibility criteria 
as the main study. After providing verbal consent, pilot participants completed the draft 
survey in private on a laptop computer. They were asked to make note of questions that 
were confusing, embarrassing, or in need of additional response options. After finishing 
the survey, participants completed a de-brief session with study personnel to discuss their 
notes and overall user experience with the pilot survey interface. Participants received a 
$15 gift card at the end of the session. Feedback was positive overall and prompted minor 
modifications to the survey instrument. Data from pilot surveys were excluded from this 
analysis. 
 The online survey for the large-scale study was conducted from February 2016 to 
March 2017. Women who screened eligible were e-mailed a unique survey link and 
 55 
reminded one week later if they had not yet completed the survey. The first page of the 
survey covered all the elements of informed consent and asked participants to indicate 
their agreement before starting the survey. Participants received a $10 gift card upon 
completing the survey.  
 
Measures  
We derived our outcome variable of contraceptive lapse using measures of 
contraceptive use and sexual activity during travel. Participants selected all the 
contraceptive methods they used at any point during their trip from a checklist and, for 
each method, were routed to follow-up questions evaluating their adherence or errors in 
use. With these data, we first classified each participant’s lapse status at the method level 
(Table 8, p.49). Details to our approach are as follows: First, for hormonal methods, we 
classified lapse irrespective of travelers’ sexual activity. Such lapses (e.g., missed pills) 
are inherently risky because they require women to be abstinent or use back-up 
contraception some days or weeks into the future, when lapse potentially manifests in the 
physiologic precursors to pregnancy (e.g., ovulation). Second, for condoms and 
withdrawal, we designated lapse only in exclusive users to rule out the possibility of dual 
method use. Data that we collected only for travelers’ last sexual encounter indicated that 
most women who used condoms or withdrawal did so in conjunction with other 
contraceptive methods (55% and 94%, respectively). Third, women who did not report 
using any contraception were classified as lapsing if they had male sex partners while 
traveling. After coding at the method level, we aggregated lapse across all the 
participant’s reported methods, resulting in a binary variable denoting lapse on any 
method. The reference group of non-lapsers therefore included contraceptive users 
without method-specific lapse as well as non-users who were not sexually active during 
travel; in a sensitivity analysis, we re-ran models restricted to those who were sexually 
active.   
To evaluate potential correlates of contraceptive lapse, we selected variables from 
the substantial literature outlining the determinants of women’s SRH in non-travel 
contexts and operationalized them for the travel setting. We also incorporated measures 
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from the small body of research among female international travelers on correlates of 
new sexual partnerships,102,109,114 condom use,91,102,113 or STI positivity112. 
Baseline and pre-travel variables. Baseline characteristics consisted of age, 
student status (undergraduate or graduate/professional), pregnancy history, STI history, 
past use of emergency contraception (EC), and having a regular SRH care provider. We 
also measured sensation seeking, a personality trait denoting a predisposition toward 
novel experiences and sensations, using the 8-item Brief Sensation Seeking Scale (BSSS; 
a=0.81-0.82); summary scores were calculated for all participants missing no more than 
one item.140 Participants reported their relationship status prior to departure and rated 
their agreement with the statement, “I expected to have sex on this trip” on a five-point 
scale ranging from “definitely not” to “definitely.” They also reported their number of 
lifetime international trips, whether and where they received pre-travel health services, 
and whether they carried travel health insurance. 
Travel characteristics and experiences. Travelers listed their trip destination in 
an open text field, which we collapsed into five regions: Europe, Central/South America, 
Asia Pacific, Mexico/Caribbean, and Multiple/other. Travel purpose and residence were 
measured with pre-populated checklists and open text fields for “other.” Participants who 
selected more than one category for either question were further prompted to classify the 
primary purpose or type of residence. We calculated trip duration as the difference 
between participants’ departure and return dates. Participants described their traveling 
companions using a checklist of seven categories (e.g., friend, family member, romantic 
partner) plus an open text field; those who didn’t select any category were classified as 
traveling alone. We gauged language barriers in the travel destination in terms of how 
participants perceived their frequency (five-point scale ranging from “never” to “always) 
and degree of impact (four-point scale anchored by “not at all” and “to a great extent”). 
Participants indicated how difficult they thought it would have been for them to access 
contraception, condoms, and abortion in their travel destination; they responded to each 
question with a five-point response scale: very easy, easy, not sure, difficult, or very 
difficult. Lastly, we asked participants to estimate the number of alcoholic drinks they 
consumed per week during their travel, whether they ever consumed four or more drinks 
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in one occasion (defined in analysis as binge drinking) and whether they used 
recreational drugs during travel. 
SRH characteristics during travel. We asked participants whether they had sex 
during travel and the gender of their sex partner(s). Women who had sex with men 
reported number of male sex partners and described those partner(s) using a checklist of 
non-mutually exclusive categories: boyfriend/partner, friend/traveling companion, casual 
acquaintance/stranger, local resident, or traveler from another country. They also 
indicated whether any male sex partners were new (“men you had not had sex with 
before this trip”). Participants were asked whether they were expecting to have sex on 
their trip; those who reported “probably not” or “definitely not”, but reported male sex 
partners for their trip, were classified as having unexpected sex.  
 In addition to the contraceptive measures used to derive our outcome variable, the 
survey included several dichotomous measures of participants’ contraceptive-related 
behaviors and experiences while traveling: had trouble communicating with a male sex 
partner about contraception, brought condoms, brought EC, used EC, didn’t have 
contraception on hand when it was needed, started a new contraceptive method, switched 
methods, had trouble maintaining their contraception schedule due to changes in time 
zones, and had trouble finding a place to get contraception. Participants also reported 
their level of satisfaction with their contraceptive method(s) during travel, which we 
collapsed into a binary variable for analysis. 
 
Analysis 
 We examined univariate distributions of all variables and crude bivariate 
associations of baseline characteristics, travel characteristics, and SRH variables 
(including contraceptive type) with lapse. We also calculated the prevalence of 
contraceptive lapse within each level of each correlate. The statistical significance of 
bivariate comparisons was evaluated using the chi-square statistic or Fisher’s exact test 
for categorical variables and student’s t-test or Wilcoxon rank-sum test for continuous 
variables.  
 In order to determine which correlates were independently associated with lapse, 
we computed adjusted relative risks (RRs) in a multivariable modified Poisson regression 
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model with robust standard errors.153 We included all variables from bivariate analysis 
that were related to lapse at p<0.20 and had at least five observations in each cell. The 
model was built cumulatively by variable domain: baseline and pre-travel variables, trip 
and travel destination variables, and then SRH-related travel variables. We evaluated 
different categorizations of variables to improve statistical efficiency and model fit. 
Within each domain, we entered all correlates simultaneously and dropped variables with 
p≥.20 before moving to the next domain. After all domains were accounted for, we 
purged any variables remaining in the model with p≥.20. Observations with missing data 
for model covariates (n=7, 2%) were excluded. We ran two supplemental models, one 
restricted to contraceptive pill users and the other to sexually active participants, to 
evaluate the robustness of our findings.  
 We did not perform a sample size calculation for this analysis due to its 
exploratory nature and the lack of prior studies describing the prevalence of women’s 
contraceptive lapse during international travel. All analyses were done using StataSE 
14.2 (StataCorp; College Station, Texas). 
 
Results 
 
 During recruitment for the main study, 1,369 women self-screened on the study 
website and 785 were deemed ineligible. The most common reason for study exclusion 
was having no history of sex. Of the 584 women meeting criteria for the main study, 379 
were considered for this analysis because they had completed an international trip in the 
three months prior to screening. Twelve (3.2%) opted out at the end of the screening 
questionnaire; thus, the remaining 367 (96.8%) were e-mailed a link to the survey. After 
excluding participants who did not respond to the link (n=21), provided an invalid e-mail 
address (n=1), or discontinued the survey before completing the questions about their 
SRH during travel (n=5), we were left with 340 observations for analysis (89.7% of 
eligible).  
 The sample was comprised of mostly undergraduate students (n=286, 84.6%), 
with a mean age of 21.1 years (Table 13). Twenty-one participants (6.2%) reported a 
prior STI diagnosis and only four (1.2%) had ever been pregnant (data not shown). 
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Almost half of the sample (n=154, 45.3%) reported using EC in the past. Most 
participants had a regular provider of SRH care (81.7%) and had travelled internationally 
before the index trip (90.0%).     
Overall, 29% (99/340) of the participants had a contraceptive lapse during travel 
(Table 13, fourth column). In bivariate analysis, lapse was significantly more prevalent 
among participants who reported having a regular provider of SRH care (31.4%) 
compared to those who didn’t (17.7%) and lapsers scored significantly higher on 
sensation seeking. Participants who attended a health clinic prior to their departure were 
more likely to lapse (34.5% vs. 25.3%; p=.06). The prevalence of lapse did not vary by 
many other baseline and pre-travel characteristics including age, relationship status, and 
history of international travel. 
 Several travel characteristics or experiences were associated with lapse in 
bivariate analysis (Table 14). Lapse prevalence varied by trip purpose: leisure (22%), 
academic (33.5%) or work/volunteer (37.5%). Women who lapsed took significantly 
longer trips than non-lapsers and the prevalence of lapse roughly increased with trip 
duration categories. Lapse was also more common among participants who traveled with 
friends (39.4%; p=.001) or a study-abroad program representative (46.9%; p=.02), 
compared to other travel companions. Lapse prevalence increased linearly with both the 
perceived frequency and perceived impact of language barriers while traveling. We also 
observed a linear pattern for perceived accessibility of abortion: the proportion of lapsers 
was lowest among participants perceiving it as easy to access (14.3%) and highest among 
those who thought it would be difficult (39.7%). Almost 57% of the travelers reported at 
least one episode of binge drinking and contraceptive lapse was more frequent among 
binge drinkers (33.2% vs. 23.3%, p=.05). 
 The contraceptive method most frequently used during travel was the pill 
(50.0%), while 23.2% of the travelers didn’t use any method (Table 15). Condom use 
was also common (19.7%; data not shown), although only 5.0% of the sample relied on 
condoms as their sole method. The prevalence of lapse was highest among users of the 
pill or ring (both 50%) compared to other methods, although there were only 12 ring 
users. Among pill lapsers, one-third (29/85) missed one pill, another third (29/85) missed 
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two pills, and the remaining third (27/85) reported missing three or more pills (data not 
shown).  
The prevalence of contraceptive lapse did not vary by number of sexual partners, 
partner type, having a new sexual partner, or having sex that was not expected (Table 
15).  Lapse prevalence was 50% or greater among women who had trouble 
communicating with a male sex partner about contraception (57.1%), didn’t have 
contraception on hand when it was needed (50%), or had trouble maintaining their 
contraception schedule due to changes in time zones (52%). Only 10 women brought EC 
on their trip, but 70.0% of them had a contraceptive lapse (p=.008). 
  In multivariable analysis (Table 16), six correlates were independently related to 
contraceptive lapse. Compared to women traveling for one week or less, women on 
longer trips were at greater risk of lapse; we collapsed all categories beyond 30 days 
because risk estimates were similar (RR range 1.70—2.37, data not shown). The 
likelihood of lapse increased with the perceived impact of language barriers, though in a 
less linear fashion as we observed in bivariate analysis. Lapse risk was 70-80% higher 
among participants who: were the most affected by language barriers (vs. not at all), 
perceived abortion to be difficult to access in their travel destination (vs. easy or not 
sure), or had trouble communicating with a travel sex partner about contraception. Pill 
users were more likely to lapse than women who used other or no contraception (RR 
4.51, 2.57—7.94). Even after accounting for pill use, participants who had trouble 
maintaining their contraception schedule because of time zone changes were at higher 
risk of lapse (RR 1.38, 95% CI 1.00—1.91). Our findings were mostly consistent in 
sensitivity analyses restricted to pill users and participants who had sex with men during 
their trip (Appendix D). In the latter model, the effect estimate for pill use was attenuated 
(RR 2.47, 95% CI 1.14—5.35).          
 
Discussion  
 
Based on our literature search, we believe this study is the first to quantify 
women’s adherence to contraception, other than condoms, during international travel. 
While official US traveler statistics are not tabulated by age and SRH characteristics, the 
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sheer volume of trips suggests that millions of US women who do not desire pregnancy 
travel abroad each year.54,56 Thus, it is important to elucidate how travel affects women’s 
contraceptive behaviors. 
In this study, nearly one-third of international travelers had a contraceptive lapse. 
These findings are largely driven by high proportions of both pill use (50%) and pill lapse 
(50%). Lapse estimates for non-traveling pill users—38% in the past three months49 and 
47% in a single cycle166—are lower than ours despite covering longer time frames. (In 
our sample, trips were 18 days on average.) Future studies should confirm whether travel 
exacerbates pill lapse relative to women’s routine environments.  
We identified correlates of contraceptive lapse that are travel-specific but relate to 
existing research of non-traveling populations. Women’s challenges with daily pill-taking 
are well documented (e.g., 167) and were evident in our study. We noted disruptions from 
changes in time zones, which is conceptually similar to reasons women have given for 
missed pills outside of international travel: exhaustion, irregular schedules, being 
temporarily away from home, and forgetfulness.165 Our findings are also consistent with 
emerging research linking women’s contraception-specific communication with sex 
partners to more consistent contraceptive use.168 During travel, partner communication 
may be hindered by linguistic and cultural barriers.  
Women’s perceptions of language barriers and abortion services in their 
destination were independently associated with contraceptive lapse, but mechanisms are 
unclear. Negative perceptions may be markers of individual factors (e.g., stress, anxiety, 
poor acclimatization, personality traits) or destination characteristics that affected 
women’s contraceptive behaviors. These factors warrant further exploration in other 
studies.  
Our findings suggest a critical role for healthcare providers. Forty-two percent of 
our participants sought healthcare before their trip and 82% had a regular SRH provider. 
Clinical encounters offer opportunities for pre-travel intervention. For women of 
reproductive age, pre-departure counseling should address pregnancy prevention 
strategies, adequacy of contraceptive supplies, preparedness for unexpected sexual 
encounters, and adjusting contraceptive schedules to travel itineraries. Our findings 
suggest that guidance is particularly important for pill users, who were most vulnerable to 
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travel-associated lapse. Counseling and referrals for long-acting reversible contraception 
may also be prudent, especially for long-term travelers who anticipate contraceptive 
challenges.  
We echo previous calls for the routine offering of EC to female travelers. 67 EC 
can provide a vital safety net for reproductive-aged women traveling in any unfamiliar 
setting, but particularly where SRH services are inaccessible. Our sample was 
experienced with EC, but few travelers brought their own supply. Lapse was more 
common among women who brought EC with them (n=10), which may reflect pre-travel 
anticipation of lapse, but we cannot draw firm conclusions from such small numbers.  
 Methodological strengths of this study include its high response rate and 
evaluation of potential correlates based on theory and prior evidence. We also note 
limitations. First, we cannot verify the temporal or causal relationships among our cross-
sectional measures. Second, while standards for the measurement of contraceptive 
adherence are lacking,169 our dichotomous outcome does not capture the severity or 
frequency of contraceptive lapse. Third, we have conservatively estimated lapse by 
excluding condom and withdrawal errors reported by women using other methods. 
Fourth, recall may have been less reliable for participants with longer trips or differential 
by lapse status. However, measures of sexual and contraceptive behaviors have shown 
good test-retest reliability up to six months’ retrospection158-161 and three-month 
retrospective measures of pill adherence perform similarly to prospective measures.170 
Fifth, social desirability bias may have affected our self-reported measures, although 
internet-based surveys such as ours are superior to other modes for eliciting sensitive 
data.162 Lastly, our study may not be generalizable beyond similar populations of female 
university students. 
 Ultimately, this study characterizes a unique population of women who are at risk 
of unintended pregnancy and suggests many opportunities for providers specializing in 
SRH, travel medicine, or primary care to meet their unique healthcare needs.
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  Table 12. Potential effects of international travel on women’s contraceptive use or pregnancy risk 
Travel characteristic Potential effects 
Physiological 
Jet lag 
 
 
• Alteration of menstrual cycle 
• Disruptions in contraceptive schedules 
Gastrointestinal illness  • Decreased absorption of oral contraceptive pills 
Psychosocial  
New social networks 
 
 
• New sexual partners 
• Unanticipated sexual encounters 
Increased autonomy & anonymity • Increases in sexual risk-taking 
Changes in daily routine • Disruptions in contraceptive schedules 
Language barriers • Miscommunication with sexual partners 
• Difficulty navigating healthcare systems 
Structural 
Poor transportation infrastructure;  
Restrictive SRH policies 
 
• Diminished access to contraception, EC, or abortion 
• Diminished access to contraception, EC, or abortion 
Liberal substance use policies • Increased substance use and sexual risk-taking 
Unregulated drugs & devices • Decreased safety and effectiveness in local contraceptives 
Cultural 
Permissive cultural norms 
 
• Increased substance use and sexual risk-taking  
Violence • Sexual assault 
• Theft of baggage housing contraceptives 
EC=Emergency contraception; SRH=Sexual and reproductive health. 
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Table 13. Baseline and pre-travel characteristics by contraceptive lapse status  
 
All participants 
Contraceptive lapse 
during travel 
No contraceptive 
lapse during travel 
Prevalence 
of lapse (%) 
p-
valuea 
      
Total 340 (100.0) 99 (100.0) 241 (100.0) 29.1 N/A 
Age at survey (years) 
Mean±SD 
18-19 
20-21 
22-29 
 
21.1±2.3 
69 (20.7) 
167 (50.2) 
97 (29.1) 
 
21.2±2.3 
19 (19.8) 
51 (53.1) 
26 (27.1) 
 
21.1±2.3 
50 (21.1) 
116 (49.0) 
71 (30.0) 
 
N/A 
27.5 
30.5 
26.8 
 
.83 
.78 
Student status 
Undergraduate 
Graduate/professional 
 
286 (84.6) 
52 (15.4) 
 
85 (85.9) 
14 (14.1) 
 
201 (84.1) 
38 (15.9) 
 
29.7 
26.9 
 
.68 
History of STI diagnosis 
Yes 
No 
 
21 (6.2) 
319 (93.8) 
 
4 (4.0) 
95 (96.0) 
 
17 (7.1) 
224 (93.0) 
 
19.1 
81.0 
 
.22 
History of emergency contraception use 
Yes  
No 
 
154 (45.3) 
186 (54.7) 
 
51 (51.5) 
48 (48.5) 
 
103 (42.7) 
138 (57.3) 
 
33.1 
25.8 
 
.14 
Has a regular SRH care provider 
Yes  
No 
 
277 (81.7) 
62 (18.3) 
 
87 (88.8) 
11 (11.2) 
 
190 (78.8) 
51 (21.2) 
 
31.4 
17.7 
 
.03 
Sensation-seeking scoreb  
Mean±SD 
 
3.5±0.6 
 
3.6±0.6 
 
3.4±0.7 
 
N/A 
 
.02 
Relationship status prior to trip 
Single 
In a casual or dating relationship 
In a serious relationship 
 
138 (40.6) 
59 (17.4) 
143 (42.1) 
 
41 (41.4) 
22 (22.2) 
36 (36.4) 
 
97 (40.3) 
37 (15.4) 
107 (44.4) 
 
29.7 
37.3 
25.2 
 
.22 
Expectations for sex during tripc 
Probably or definitely not 
Maybe 
Probably or definitely 
 
222 (65.7) 
49 (14.5) 
67 (19.8) 
 
60 (61.9) 
19 (19.6) 
18 (19.6) 
 
162 (67.2) 
30 (12.5) 
49 (20.3) 
 
27.0 
38.8 
26.9 
 
.24 
History of any international travel 
Yes 
No 
 
306 (90.0) 
34 (10.0) 
 
91 (91.9) 
8 (8.1) 
 
215 (89.2) 
26 (10.8) 
 
29.7 
23.5 
 
.45 
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Attended any clinic in preparation for trip 
Yes  
No 
 
142 (41.8) 
198 (58.2) 
 
49 (49.5) 
50 (50.5) 
 
93 (38.6) 
148 (61.4) 
 
34.5 
25.3 
 
.06 
Attended travel medicine clinic before trip  
Yes  
No 
 
73 (21.5) 
267 (78.5) 
 
26 (26.2) 
73 (73.7) 
 
47 (19.5) 
194 (80.5) 
 
35.6 
27.3 
 
.17 
Obtained travel health insurance for trip 
Yes 
No 
Not sure 
 
202 (59.4) 
117 (34.4) 
21 (6.7) 
 
66 (66.7) 
28 (28.3) 
5 (5.1) 
 
136 (56.4) 
89 (36.9) 
16 (6.6) 
 
32.7 
23.9 
23.8 
 
.22 
Table entries are n(%) unless otherwise specified. aP-values correspond to X2 statistic for categorical variables and t-test for continuous variables. bScores are 
means from 8-item scale with items scored from 1 (low sensation-seeking) to 5 (high sensation-seeking). cNo pre-travel expectation to have sex, but was 
sexually active on trip. N/A=Not applicable; SD=standard deviation; SRH=sexual and reproductive health; STI=sexually transmitted infection. 
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Table 14. Travel characteristics and experiences by contraceptive lapse status 
 
All participants 
Contraceptive lapse 
during travel 
No contraceptive 
lapse during travel 
Prevalence of 
lapse (%) p-valuea 
      
Total 340 (100.0) 99 (100.0) 241 (100.0) 29.1 N/A 
Travel destination (region) 
Europe 
Central/South America 
Asia Pacific 
Mexico/Caribbean 
Multiple/Other 
 
137 (40.3) 
63 (18.5) 
45 (13.2) 
42 (12.4) 
53 (15.6) 
 
44 (44.4) 
20 (20.2) 
12 (12.1) 
8 (8.1) 
15 (15.2) 
 
93 (38.6) 
43 (17.8) 
33 (13.7) 
34 (14.1) 
38 (15.8) 
 
32.2 
31.8 
26.7 
19.1 
28.3 
 
.56 
Trip purpose 
Academic 
Leisure 
Work/volunteer 
 
164 (48.2) 
144 (42.4) 
32 (9.4) 
 
55 (55.6) 
32 (32.3) 
12 (12.1) 
 
109 (45.2) 
112 (46.5) 
20 (8.3) 
 
33.5 
22.2 
37.5 
 
.05 
Primary travel residence  
Hotel or resort 
Apartment or rental home 
Host family 
Local friend or family member 
Hostel 
Other 
 
97 (28.5) 
80 (23.5) 
64 (18.8) 
35 (10.3) 
35 (10.3) 
29 (8.5) 
 
22 (22.2) 
28 (28.3) 
21 (21.2) 
9 (9.1) 
8 (8.1) 
11 (11.1) 
 
75 (31.1) 
52 (21.6) 
43 (17.8) 
26 (10.8) 
27 (11.2) 
18 (7.5) 
 
22.7 
35.0 
32.8 
25.7 
22.9 
37.9 
 
.34 
Trip duration  
Median (range) in days 
1 to 7 days 
8 to 14 days 
15 to 30 days 
31 to 120 days 
121-365 days 
 
18 (2-361) 
60 (17.8) 
81 (24.0) 
68 (20.2) 
56 (16.6) 
72 (21.4) 
 
56.5 (2-361) 
9 (9.2) 
20 (20.4) 
16 (16.3) 
26 (26.5) 
27 (27.6) 
 
16 (3-339) 
51 (21.3) 
61 (25.5) 
52 (21.8) 
30 (12.6) 
45 (18.8) 
 
N/A 
15.0 
24.7 
23.5 
46.4 
37.5 
 
<.001 
.001 
Traveling companionsb 
Other student(s) 
Friend(s) 
Family member(s) 
Professor 
Romantic partner 
 
159 (46.8) 
127 (37.4) 
95 (27.9) 
59 (17.4) 
48 (14.1) 
 
52 (52.5) 
50 (50.5) 
26 (26.3) 
17 (17.2) 
17 (17.2) 
 
107 (44.4) 
77 (32.0) 
69 (28.6) 
42 (17.4) 
31 (12.9) 
 
32.7 
39.4 
27.4 
28.8 
35.4 
 
.17 
.001 
.66 
.96 
.30 
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Study abroad program representative 
Travel guide or translator 
Supervisor 
None  
32 (9.4) 
22 (6.5) 
14 (4.2) 
33 (9.7) 
15 (15.2) 
5 (5.1) 
4 (4.0) 
11 (10.9) 
17 (7.1) 
17 (7.1) 
10 (4.2) 
22 (9.2) 
46.9 
22.7 
28.6 
33.3 
.02 
.50 
1.00 
.63 
Language barriers: Perceived frequency 
Never or rarely 
Sometimes 
Very often or always 
 
117 (34.4) 
118 (34.7) 
105 (30.9) 
 
27 (27.3) 
32 (32.3) 
40 (40.4) 
 
90 (37.3) 
86 (35.7) 
65 (27.0) 
 
23.1 
27.1 
38.1 
 
.04 
Language barriers: Perceived degree of impact  
Not at all 
A little 
Somewhat 
To a great extent 
 
107 (31.5) 
138 (40.6) 
77 (22.7) 
18 (5.3) 
 
21 (21.2) 
12 (41.4) 
29 (29.3) 
8 (8.1) 
 
86 (35.7) 
97 (40.3) 
48 (19.9) 
10 (4.2) 
 
19.6 
29.7 
37.7 
44.4 
 
.02 
Perceived accessibility of contraception in destination 
Easy or very easy 
Not sure  
Difficult or very difficult  
 
56 (16.5) 
172 (50.7) 
111 (32.7) 
 
18 (18.2) 
41 (41.4) 
40 (40.4) 
 
38 (15.8) 
131 (54.6) 
71 (29.6) 
 
32.1 
23.8 
36.0 
 
.08 
Perceived accessibility of condoms in destination 
Easy or very easy  
Not sure  
Difficult or very difficult 
 
227 (67.2) 
75 (22.2) 
36 (10.7) 
 
67 (68.4) 
17 (17.4) 
14 (14.3) 
 
160 (66.7) 
58 (24.2) 
22 (9.2) 
 
29.5 
22.7 
38.9 
 
.20 
Perceived accessibility of abortion in destination 
Easy or very easy 
Not sure  
Difficult or very difficult 
 
14 (4.1) 
169 (49.9) 
156 (46.0) 
 
2 (2.0) 
35 (35.4) 
62 (62.6) 
 
12 (5.0) 
134 (55.8) 
94 (39.2) 
 
14.3 
20.7 
39.7 
 
<.001 
Number of alcoholic drinks consumed per week 
None 
1 to 7 drinks 
8 to 21 drinks 
22 drinks or more 
 
32 (9.4) 
206 (60.8) 
82 (24.2) 
19 (5.6) 
 
9 (9.1) 
62 (62.6) 
25 (25.3) 
3 (3.0) 
 
23 (9.6) 
144 (60.0) 
57 (23.8) 
16 (6.7) 
 
28.1 
30.1 
30.5 
15.8 
 
.65 
Had ≥1 episode of binge drinkingc  
Yes 
No 
 
193 (56.9) 
146 (43.1) 
 
64 (65.3) 
34 (34.7) 
 
129 (53.5) 
112 (46.5) 
 
33.2 
23.3 
 
.05 
Used recreational drugs 
Yes 
No 
 
75 (22.1) 
265 (77.9) 
 
25 (25.3) 
74 (74.8) 
 
50 (20.8) 
191 (79.3) 
 
33.3 
27.9 
 
.36 
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Table entries are n(%) unless otherwise specified. aP-values correspond to X2 statistic or Fisher’s exact test for categorical variables and Wilcoxon rank-sum test 
for continuous variables. bCategories not mutually exclusive. N/A=Not applicable. c≥4 drinks in one occasion. SD=standard deviation. 
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Table 15. Sexual and reproductive health characteristics during travel by contraceptive lapse status 
 All 
participants 
Contraceptive lapse 
during travel 
No contraceptive 
lapse during travel 
Prevalence of 
lapse (%) 
p-
valuea 
Total 340 (100.0) 99 (100.0) 241 (100.0) 29.1 N/A 
Contraceptive method(s) used:b 
Implant 
Intrauterine device 
Injectable 
Pill 
Patch 
Ring 
Condom (exclusive users)c 
Withdrawal (exclusive users)c 
Natural family planning 
No method 
 
14 (4.1) 
39 (11.5) 
4 (1.2) 
170 (50.0) 
3 (0.9) 
12 (3.5) 
17 (5.0) 
2 (0.6) 
3 (0.9) 
79 (23.2) 
 
0 (0.0) 
1 (1.0) 
1 (1.0) 
85 (85.9) 
1 (1.0) 
6 (6.1) 
3 (3.0) 
1 (1.0) 
0 (0.0) 
2 (2.0) 
 
14 (5.8) 
38 (15.8) 
3 (1.2) 
85 (35.3) 
2 (0.8) 
6 (2.5) 
14 (5.8) 
1 (0.4) 
3 (1.2) 
77 (32.0) 
 
0.0 
2.6 
25.0 
50.0 
33.3 
50.0 
17.7 
50.0 
0.0 
2.5 
 
.01 
<.001 
1.0 
<.001 
1.0 
.11 
.41 
.50 
.56 
<.001 
Number of male sex partners 
None 
1 partner 
2 or more partners 
 
232 (68.2) 
82 (24.1) 
26 (7.7) 
 
65 (65.7) 
26 (26.3) 
8 (8.1) 
 
167 (69.3) 
56 (23.2) 
18 (7.5) 
 
28.0 
31.7 
30.8 
 
.80 
Type of male sex partner(s)d 
Boyfriend or partner 
Friend or traveling companion  
Casual acquaintance or stranger 
Local resident 
Traveler from another country 
 
62 (18.2) 
26 (7.7) 
24 (7.1) 
24 (7.1) 
17 (5.0) 
 
23 (23.2) 
5 (5.1) 
9 (9.1) 
6 (6.1) 
3 (3.0) 
 
39 (16.2) 
21 (8.7) 
15 (6.2) 
18 (7.5) 
14 (5.8) 
 
37.1 
19.2 
37.5 
25.0 
17.7 
 
.13 
.25 
.35 
.65 
.41 
Had sex with new male partner(s) 
Yes  
No 
 
59 (17.4) 
281 (82.7) 
 
16 (16.2) 
83 (83.8) 
 
42 (17.6) 
197 (82.4) 
 
27.1 
29.5 
 
.71 
Had unexpected sexe 
Yes  
No 
 
25 (7.4) 
315 (92.7) 
 
9 (9.1) 
90 (90.9) 
 
16 (6.6) 
225 (93.4) 
 
36.0 
28.6 
 
.43 
Had trouble communicating with male partner about 
contraception 
Yes  
No 
 
 
14 (4.2) 
323 (95.9) 
 
 
8 (8.3) 
89 (91.8) 
 
 
6 (2.5) 
234 (97.5) 
 
 
57.1 
27.6 
 
 
.02 
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Brought condoms on trip 
Yes 
No 
 
63 (18.5) 
277 (81.5) 
 
17 (17.2) 
82 (82.8) 
 
46 (19.1) 
195 (80.9) 
 
27.0 
29.6 
 
.68 
Brought emergency contraception on trip 
Yes 
No 
 
10 (2.9) 
330 (97.1) 
 
7 (7.1) 
92 (92.9) 
 
3 (1.2) 
238 (98.8) 
 
70.0 
27.9 
 
.008 
Used emergency contraception 
Yes 
No 
 
6 (1.8) 
334 (98.2) 
 
2 (2.0) 
97 (98.0) 
 
4 (1.7) 
237 (98.3) 
 
33.3 
29.0 
 
1.0 
Didn’t have contraception on hand when needed 
Yes 
No 
 
28 (8.3) 
311 (91.7) 
 
14 (14.3) 
84 (85.7) 
 
14 (5.8) 
227 (94.2) 
 
50.0 
27.0 
 
.01 
Initiated or switched contraceptive method(s) 
Yes 
No 
 
12 (3.5) 
328 (96.5) 
 
4 (4.0) 
95 (96.0) 
 
8 (3.3) 
233 (96.7) 
 
33.3 
29.0 
 
.74 
Had trouble maintaining contraception schedule due to 
travel across time zones 
Yes 
No 
 
 
102 (30.1) 
237 (69.9) 
 
 
53 (54.1) 
45 (45.9) 
 
 
49 (20.3) 
192 (79.7) 
 
 
52.0 
19.0 
 
 
<.001 
Had trouble finding a place to get contraception 
Yes  
No 
 
25 (7.4) 
314 (92.6) 
 
10 (10.2) 
88 (89.8) 
 
15 (6.2) 
226 (93.8) 
 
40.0 
28.0 
 
.20 
Dissatisfied with contraceptive method(s)  
Yes 
No 
 
37 (11.0) 
301 (89.1) 
 
11 (11.1) 
88 (88.9) 
 
26 (10.9) 
213 (89.1) 
 
29.7 
29.2 
 
.95 
Table entries are n(%) unless otherwise specified. aP-values correspond to X2 statistic or Fisher’s exact test. bCategories are not mutually exclusive, although 
only 3 (0.9%) participants overlapped categories: implant + pill (n=1), intrauterine device + ring (n=1), and intrauterine device + natural family planning (n=1). 
cData are limited to users who did not report using any other contraceptive method. dCategories are not mutually exclusive. eNo pre-travel expectation to have 
sex, but was sexually active on trip.  
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Table 16. Relative risk of contraceptive lapse during international travel (n=333) 
 Crude Adjusted 
 
RR 95% CI RRa 95% CI 
Duration of trip 
1 to 7 days  
8 to 30 days 
More than 30 days 
 
1.00 (ref.) 
1.59 
2.65 
 
 
0.82—3.10 
1.40—5.03 
 
1.00 (ref.) 
1.39 
2.02 
 
 
0.76—2.54 
1.14—3.57 
Language barriers: Perceived degree of impact  
Not at all  
A little 
Somewhat 
To a great extent 
 
1.00 (ref.) 
1.56 
1.90 
2.31 
 
 
0.97—2.49 
1.16—3.12 
1.21—4.43 
 
1.00 (ref.) 
1.41 
1.44 
1.77 
 
 
0.94—2.13 
0.93—2.21 
1.02—3.08 
Perceived accessibility of abortion in destination 
Difficult to access  
Easy to access / Not sure  
 
1.96 
1.00 (ref.) 
 
1.38—2.79 
 
1.67 
1.00 (ref.) 
 
1.22—2.27 
Contraceptive method 
Pill 
Other/None 
 
5.89 
1.00 (ref.) 
 
3.48—9.96 
 
4.51 
1.00 (ref.) 
 
2.57—7.94 
Had trouble communicating with male sex partner about contraception 
Yes 
No 
 
2.07 
1.00 (ref.) 
 
1.27—3.37 
 
1.79 
1.00 (ref.) 
 
1.16—2.75 
Had trouble maintaining contraception schedule due to travel across time 
zones 
Yes 
No 
 
2.75 
1.00 (ref.) 
 
1.99—3.82 
 
1.38 
1.00 (ref.) 
 
1.00—1.91 
aRelative risks are mutually adjusted for all covariates in the table. Covariates significant at p<.20 were retained in the final multivariable model. 
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Chapter 5 
 
Manuscript 3 
A qualitative exploration of young women’s sexual and contraceptive 
behaviors during international travel 
 
Introduction 
 
 Adolescence and young adulthood are pivotal life stages for relationship 
formation and accordingly, for maintaining one’s sexual and reproductive health (SRH). 
Decades of research have aimed to elucidate the determinants of SRH, including sexual 
and contraceptive behaviors, among youth. One key insight from this body of work is that 
SRH behaviors are not only multifactorial, but also context specific. Finding greater 
variation in sexual risk behaviors within than between adolescents followed through early 
adulthood, Cooper described the behaviors as a “complex product of the person, the 
situation, and the relationship context.”171 Indeed, longitudinal studies show differences 
in use of contraception and condoms by relationship factors such as level of 
commitment,37,172 sexual communication with partners,173,174 and partner support for 
contraception.174 Other studies of sexual risk-taking among youth have isolated the effect 
of event-level alcohol use from their global drinking behaviors.53,172 More knowledge of 
how youth’s SRH risk behaviors operate within specific contexts could guide the creation 
of more potent interventions.   
 International travel is one experience that may trigger significant shifts in the 
context surrounding SRH behaviors. Given its increasing popularity, foreign travel 
warrants further research into its implications for SRH, especially for youth. In 2016 
there were over 72 million trips from the United States to international destinations, an 
annual increase of 8%; 11% of travelers listed their occupation as “student.”54,55 Studying 
abroad, a type of travel specific to youth, entails longer and potentially more immersive 
experiences than other trips which may increase SRH risk. US students’ participation in 
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formal study-abroad programs has grown 52% over the past decade, to over 300,000 U.S. 
students in the 2014-2015 academic year.57  
 Most of the travel health literature is devoted to topics unrelated to SRH, but the 
spread of HIV and sexually transmitted infections (STIs) across international borders has 
directed attention toward travelers’ sexual health. Studies have reported on the prevalence 
and correlates of STI acquisition and underlying risk behaviors—e.g., “casual” sex, new 
sexual partners, and unprotected sex—among international travelers.101,106,110,112,118,175,176 
There are several gaps in the current literature. First, most of the samples are drawn from 
STI clinics, youth hostels, and other high-risk settings; behaviors in the general 
population of travelers are less defined. Second, studies that examine independent 
correlates of SRH outcomes report inconsistent findings. Third, it is unclear how risk 
mechanisms differ by gender because most analyses pool data from men and women. 
Lastly, and remarkably, empirical studies of travelers’ contraceptive behaviors—other 
than condom use—are lacking. Not only would these data shed light on women’s 
motivations for condom use with travel sex partners (i.e., to prevent pregnancy, STI, or 
both), they are also essential to understanding women’s vulnerability to unintended 
pregnancy while traveling.  
 
 Research into the SRH of international travelers is must consider the complexity 
of the travel setting. Entering a new country involves an abrupt shift in one’s 
environment that may reverberate across many domains influencing SRH. For example, 
scholars have conceptualized the psychological state of travel one of anonymity, 
liminality, ephemerality, and freedom from routine roles and obligations—leading 
travelers to feel less inhibited and more prone to risky behaviors.78,80,81 International 
travelers also operate within discrete social networks that provide opportunities for new 
sexual partners. In qualitative studies, women report that their travel relationships, both 
platonic and romantic, were more intimate and progressed more quickly than at home.177-
179 Travelers are also situated within the landscape of local policies and systems that 
govern the accessibility of SRH services. Access to emergency contraception (EC) and 
abortion is highly variable both between and within countries.69,70 Finally, local 
environments are imbued with cultural norms regarding sex, gender, and substance use 
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that may foster greater risk-taking by visitors. These examples illustrate two 
methodological challenges. First, many travel-related constructs are difficult to 
operationalize into quantitative measures. Second, international travel is comprised of 
several effects that operate simultaneously, across multiple domains, and in a condensed 
time frame.  
 In sum, the impact of international travel on SRH is not fully clear due to gaps in 
the existing literature and the complex nature of travel itself. Qualitative research 
methods are well suited for characterizing complex phenomena and generating 
hypotheses for potential mechanisms.136 In this study, we use semi-structured qualitative 
interviews to explore the underpinnings of young women’s sexual and contraceptive 
behaviors during international travel. We focus on young women because of the 
disproportionate burden of STIs and unintended pregnancy borne by this age group6,17 
and the paucity of research on female travelers’ contraceptive use. To capture the breadth 
of women’s SRH experiences, including resilience to adverse outcomes, we consider 
various types of travel (i.e., purpose, duration, destination) and sample travelers from 
clinical and non-clinical settings. We address the following research questions:  
 
• What expectations do women have regarding their sexual relationships and 
contraceptive use during international travel? What reasons do they give for these 
expectations? How do women’s expectations align with their travel experiences? 
• What are the circumstances that give rise to women’s sexual encounters during 
international travel?  
• How do female travelers negotiate STI and pregnancy prevention with their male 
sex partners? 
• What are the factors that facilitate or hinder young women’s contraceptive 
adherence while traveling? 
 
 Our goals are two-fold: (1) To strengthen the body of evidence regarding the 
effects of international travel on SRH, and (2) To highlight risks to travelers’ SRH that 
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are potentially modifiable via pre-travel interventions by clinicians and other 
practitioners.     
 
Methodology 
 
Sample 
 Our data come from the International Travel and Reproductive Health Study, a 
cross-sectional, mixed-methods study conducted from October 2015 through March 
2017. The study was comprised of female university students who had recently returned 
from an international trip (“Traveler”) or were preparing to travel internationally (“Pre-
Traveler”). This analysis features the 25 Travelers and 19 Pre-Travelers who completed 
an in-depth qualitative interview. The University of Minnesota Institutional Review 
Board approved the study protocol. 
 We recruited participants from the University of Minnesota’s Twin Cities campus 
via flyers, Facebook, the campus study abroad office, and the campus travel clinic. 
Potential participants self-screened for eligibility on the study website. Inclusion criteria 
were: female, 18-29 years old, history of sex with male partner(s), understands English, 
and considers the United States their home country. Participants also had to have 
completed a travel medicine visit for their recent or upcoming trip because some aims of 
the main study pertained to the travel medicine encounter. We excluded women who 
were married, engaged, pregnant, attempting pregnancy, or sterile. Inclusion criteria were 
further defined by travel status: traveled internationally in the previous three months 
(Travelers); or plans to travel outside the United States in the next three months, with no 
international travel in the past six months (Pre-Travelers).  
 After enrolling 25 participants, we began using purposive sampling based on our 
preliminary observations of the data. For Pre-Travelers, we stopped recruiting women 
who were in relationships with men but would not be traveling with their partners. These 
participants had given highly consistent responses to questions about their expectations of 
travel sex, suggesting that additional interviews were unlikely to yield new information. 
We also instituted recruitment quota for Travelers so that at least half of the sample had 
experienced a new sexual partner, an unexpected sexual encounter, or a lapse in 
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contraceptive use while traveling. The preliminary Traveler sample skewed toward 
lower-risk SRH experiences and our goal was to explore experiences along the entire 
spectrum of risk. 
 
Data collection 
 Participants completed interviews in private rooms. Interviewers used semi-
structured guides that consisted mostly of standardized, open-ended questions. Some 
questions included optional probes that interviewers used at their discretion to encourage 
further elaboration from participants. This approach ensured consistency in the data 
collected across interviews, but also flexibility in how deeply interviewers explored each 
question with each participant. The interviews ranged in duration from 11 to 58 minutes 
with a median of 29 minutes. Participants received a $20 gift card upon completion of the 
interview. The interviews were digitally recorded and later transcribed verbatim. 
 We took several precautions to create an environment in which participants felt 
comfortable discussing their personal attitudes and experiences related to travel and SRH. 
First, all interviews were conducted by female graduate students who were unacquainted 
with the participants. Second, interviewers assured participants that there were no correct 
answers and that they could skip any questions that made them feel uncomfortable. Third, 
the interview began with questions unrelated to SRH (e.g., “What was the best part about 
your trip?”) and gradually eased into more sensitive material. Finally, interviewer 
training emphasized the importance of withholding judgment and allowing participants to 
lead their own narratives.  
 Most interview measures focused on a single, round-trip international excursion 
originating in the United States (“index trip”). For participants with multiple trips in the 
three months before (if Traveler) or after (if Pre-Traveler) the interview, the index trip 
was defined as the one closest to the interview date. For this analysis, we selected 
measures pertaining to the pre-travel period that were assessed for both Travelers and 
Pre-Travelers: trip preparations (including for SRH), expectations to have sex on the trip, 
plans for contraceptive use, and SRH-related concerns for the trip. We included 
additional measures assessed only for Travelers: sexual partnerships during travel 
(description of partner(s), conversations about pregnancy/STI prevention, condom use); 
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contraceptive methods used; contraceptive use during travel; and reflections on how 
closely their pre-travel expectations matched their travel SRH experiences.        
 Before the interview, participants completed a brief baseline survey about their 
demographic characteristics (age, undergraduate or graduate student), SRH history (age 
at first sex, history of EC use), and trip characteristics (relationship status at departure, 
destination, primary purpose, duration, traveling companions). 
 
Analysis 
 We summarized baseline characteristics using descriptive statistics. For the 
interview data, we followed qualitative analysis procedures described by Miles et al.180 In 
the first stage, we began to condense the raw text from interview transcripts by coding 
them in ATLAS.ti Mac version 1.6.0 (ATLAS.ti Scientific Software Development 
GmbH; Berlin). We drafted a codebook that reflected the content of the interview guides 
and our initial review of the transcripts. During the coding process, we made multiple 
revisions to the codebook based on our observations of the data. We used an iterative, 
double-coding process whereby the coding of each transcript was performed by a primary 
coder, reviewed by a secondary coder, and updated as needed to conform to the final 
version of the codebook. Coders met frequently to resolve discrepancies and to refine the 
code set and definitions.  
 In the second stage of analysis, we exported the data from ATLAS.ti and 
organized them in matrices by topic (e.g., contraceptive use, sexual relationships). Within 
each matrix, we further synthesized the data to identify emergent themes. Some themes 
garnered endorsement from many participants, while others were less represented but 
nevertheless salient. We verified our conclusions through multiple reviews and re-
groupings of the data. Participants could be represented under multiple themes because 
we classified them under every theme that was consistent with their responses.  
 
Results 
 
 Participants were predominantly undergraduate students with a median age of 20-
21 years (Table 17). Approximately 40% had used EC in the past and almost all (92-
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95%) were experienced with international travel. A variety of geographic regions were 
represented in participants’ travel destinations. Most participants (53-72%) were traveling 
on study abroad programs or to fulfill other academic requirements. Trip duration varied 
widely from a few days to one year. The most frequently reported contraceptive methods 
for travel were the pill (42-48%) and intrauterine device (IUD, 26-28%). 
Below, we describe our qualitative findings within four categories: (1) Pre-travel 
expectations of sex, (2) Sexual partnerships during travel, (3) Facilitators of contraceptive 
use, and (4) Barriers to contraceptive use. We feature participant quotations to illustrate 
facets of each theme.  
  
Pre-travel expectations of sex 
  Apart from those traveling with their partners, participants overwhelmingly 
thought that they would not have sex on their trip. Their rationales were varied but 
frequently centered on personal values, perceptions of limited opportunities for sex, and 
trip characteristics. We were unable to characterize travelers who were not in a 
relationship, but anticipating sexual activity on their trip, because only two participants fit 
that category. While most Travelers reported that their pre-departure expectations were 
borne out on their trip, some reported unexpected experiences.     
 Theme 1: Personal values support abstinence (n=23). Participants who were in 
relationships but traveling without their partners (n=13) voiced clear abstinence 
expectations stemming from their commitment to monogamy (e.g., “I have a pretty 
serious boyfriend…I don’t plan on doing anything to jeopardize that.”). Other travelers 
invoked personal values that were opposed to casual sex (“I’m not just going to go sleep 
with some random dude”) or relationships that become sexual too quickly (“I want to 
know them before making that connection”)—scenarios that they associated with having 
sex during travel. Some participants mentioned trip length in conjunction with value-
based statements: “I only like to have sex in committed relationships and you can’t really 
form a committed relationship in two-and-a-half months.”  
 Theme 2: Not that kind of trip (n=12). Many participants expected to be 
abstinent due to the nature of their trip. Some perceived sex as selfish or incongruent with 
their trip’s purpose: “In my mind this isn’t really like a leisure trip” and “I am just trying 
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to stay a little more professional on this trip.” According to one participant, professors 
leading her trip discouraged students from being sexually active. Some women described 
being too busy to pursue sexual relationships while traveling, or that sex would be a 
distraction to their travel goals: “I’m not even thinking about [sex]. I’ll be just so busy 
and am excited about seeing the country.” For one Pre-Traveler who had just ended a 
relationship, abstinence was a fundamental component of her trip. As she explained, “I’m 
looking forward to taking care of myself and that includes being celibate.” Others 
predicted a lack of potential sex partners given the trip duration or travel companions: 
“The trip is going to be all girls, I’m staying with a girl, I’m straight (laughs).” One 
participant articulated several reasons in this category:  
“If I were vacationing or living there, I would be sexually active. But when it’s two 
weeks and I don’t really know anyone….I’ll be busy doing what I’m there to do—being 
there with the kids and volunteering. It’s not, like, a relaxation trip.” 
 Theme 3: Abstinence for STI/HIV prevention (n=6). These participants planned 
to refrain from travel sex out of concern for STIs or HIV. While some concerns were 
unrelated to travel—“I have this guilt association with infectious diseases and so I just 
rarely have sex”—others were situated in the travel context (“I would be nervous about 
what you could potentially contract. Not just abroad, but in a country like that, too.”). A 
few participants cited the higher HIV rates in their destination, with one saying she would 
“think a whole lot harder” about having sex with a local partner than with someone in the 
United States.  
 Theme 4: Keeping things open (n=7). These participants held ambiguous 
expectations that favored abstinence, but still entertained the possibility of initiating a 
new sexual relationship while traveling. Many described their expectations in terms of 
their personality rather than of the circumstances of their index trip: “It wasn’t like I was 
going there to get laid. But I’m a pretty open person when it comes to relationships.” 
Others said they were “going there with a really open mind” and “[weren’t] planning or 
not planning” on being sexually active. Having flexible expectations was often expressed 
in terms of preparedness: “My plan was to not be involved with anybody emotionally or 
physically. But I guess I know myself pretty well, so I took birth control with me.” When 
stressing the importance of being prepared, some participants referenced their own 
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experiences with spontaneous sexual encounters. One participant drew from her past 
involvement in “hookup culture,” where sex “just happens.” 
 Theme 5: Unfulfilled abstinence expectations (n=4). Four Travelers, all on 
study-abroad trips, were sexually active despite pre-travel plans to be abstinent. Notably, 
three of them were traveling for at least six months and two remained in their destination 
longer than they originally planned. One participant, who described her travel sex 
encounter as “spur of the moment,” had anticipated dancing with men at clubs but “never 
really anything past that.” Another woman contrasted her travel “hook-ups” with her 
expectations: “I don’t think I ever would have done that if I were [in the United States]. I 
just didn’t expect to be with anybody, much less three partners.” The third Traveler was 
in a committed relationship when she left for her six-week trip and “obviously intended 
to remain monogamous,” but quickly began an intimate relationship with another student. 
The last participant went into her trip thinking, “It’s going to be a dry four months!” then 
had five sexual partners—the “polar opposite” of what she expected. Her advice to other 
women traveling: “Definitely consider your reproductive health and have plan A and then 
have a backup. Because when you travel, things will not go according to plan.” 
 
Sexual partnerships during travel 
  Travelers perceived many aspects of their index trip as facilitating new sexual 
partnerships (themes 1-3 below). For these first three themes, participants are represented 
regardless of whether they had new sex partners while traveling, although the majority 
did. For sexually active participants, we characterize both successful (theme 4) and 
unsuccessful (theme 5) experiences with using condoms and contraception, including 
negotiation with sexual partners.  
 Theme 1: Center of attention (n=8). Many women received considerably more 
attention from men in their travel destination compared to the United States. While 
reports of street harassment (i.e., “cat-calling”) were frequent, this theme denotes more 
targeted pursuits of sexual relationships. Travelers spoke of feeling like “a novelty,” 
exoticized as Westerners, and stereotyped as sexually promiscuous: “They expect us to 
be more loose and uninhibited. And there was definitely an expectation that some of us 
would have sex with men at the bars.” Travelers to Latin American countries described 
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“gringa hunting”—local men’s pursuit of white female tourists for sex. One speculated 
that the phenomenon might be partly attributable to “a lot of women who come and want 
their flings…it’s definitely from both sides.” Attention from men wasn’t always 
unreciprocated or unwelcomed and at times led to sexual encounters. One Traveler said it 
was “a lot easier to get with people down there” for women wanting to have sex. Another 
woman who met a new partner at a club described a more “expressive culture” in which 
men “woo a girl” much more assertively.     
 Theme 2: Situational disinhibition (n=6). Participants pointed to psychosocial 
features of the travel environment that fostered behavioral disinhibition and, at times, 
risky sexual behaviors. Some viewed travel as an opportunity for exploration and 
experimentation. One participant knew she would be “kind of exploring out there” but 
“went a little crazy” with the number of sexual partners she had while traveling. Women 
also alluded to “partying” atmospheres typified by casual sex and substance use, using 
both positive (“all these twenty-somethings having fun”) and negative (“crazy ex-pat 
communities”) terms. Four participants attributed their sexual risk-taking to alcohol use. 
One focused on her academic responsibilities during the week, but “things would happen 
on the weekends. Insert beer, tequila. (laughs)…drinking definitely led me to make 
[sexual] decisions that I later regretted.” Another participant was unfaithful to her 
boyfriend—something she “had never done and will never do again”—while inebriated. 
While noteworthy, such accounts were the exception across the entire sample of 
Travelers; the majority perceived no change in their drinking habits, nor did they think 
their alcohol use influenced their sexual decision-making while traveling. 
 Theme 3: Compressed intimacy (n=4). “When you’re traveling, you get to know 
people so well, so quickly because you’re with them constantly. It’s such a deep and 
intense relationship, not like here [in the United States].” This statement from a Traveler 
who had three new sex partners during her trip depicts the particularly intense 
attachments that some women forged during travel. Other women witnessed “close-knit” 
and “intimately connected” groups of travelers. One participant who had a serious partner 
back home described her unexpected attraction to a fellow student: “I was drawn to him 
because he had been there, I felt safe around him, I felt like he already knew me.” Their 
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connection was accelerated by her dependence on his familiarity with the local 
environment and culture.  
 Theme 4: Trouble with condoms or communicating with partners (n=6). These 
Travelers, all of whom had new sex partners, used condoms inconsistently or had 
problems communicating with partners about condoms or contraception. Some of these 
episodes were due to cultural barriers. One participant was surprised to encounter 
resistance to condoms from her local partners, who favored withdrawal: “They’re like 
‘Oh, I’ll just pull out.’ And I’m like, ‘I don’t even know you! And you don’t know me! 
What the heck!’ They were a little bit more belligerent.” One of her travel partners also 
removed a condom during sex without telling her. Other participants described local 
partners who avoided talking about pregnancy/STI prevention: “We didn’t have that 
conversation…the difficulties I had were cultural—not language at all.” One participant 
anticipated “pushback” from her partners on condom use if she told them she had an 
IUD, so she did not disclose her device. Another IUD user never used condoms with her 
new partner, even though they had only discussed risk of STIs, and not pregnancy, before 
their relationship became sexual. Condom troubles brought serious consequences for 
some Travelers. One participant reused a condom from the night before (with the same 
partner) and subsequently contracted herpes. Another had to use “crappy condoms from 
the grocery store” after running out of her preferred US brand and one of them broke 
during sex. With help from her partner, she found a local store that sold EC. A third 
participant neglected to use a condom because she thought she was outside her fertile 
window and subsequently became pregnant. She procured both a medication abortion and 
IUD while traveling. 
 Theme 5: Successful condom use and partner communication (n=7). 
Participants traveling with their regular partners “had things figured out” when it came to 
contraception, including condoms. For the other women who entered new sexual 
partnerships, communication was positive with at least some partners. While 
conversations were not always extensive, they were sufficient to establish that a condom 
would be used: “In general it was just like, ‘We’re going to use a condom.’ That was 
never questioned.” Two participants who were using both condoms and the pill decided 
to stop using condoms with their partners after discussing their STI status and testing 
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history. They described their partners as honest and truthful, and one appreciated that her 
partner initiated the conversation—“He was on top of things and wanted to make sure we 
were taking care of ourselves.” Another woman relied on mostly non-verbal cues to 
negotiate condom use with a partner she had met that same evening.  
 
Facilitators of contraceptive use 
 Participants identified many supporting factors in both the pre-departure and 
travel periods that contributed to their successful contraceptive use. Themes were often 
delineated by method type and methods that required more regular behaviors, such as the 
pill, elicited more extensive comments. 
 Theme 1: Method is innately low maintenance (n=11). Nine IUD users were 
confident in their ability to prevent pregnancy while traveling due to their method’s high 
effectiveness and lack of maintenance. Their comments included, “It’s inside of me—all 
there and accounted for,” “It goes with me everywhere,” and “It just lasts all the time.” 
One participant specifically mentioned travel considerations: “It was really nice that I had 
an IUD…I didn’t have to worry about bringing enough pills into the country. Pills 
definitely were not available there.” Another traveler did not have to arrange for 
refrigeration of her vaginal ring because her trip fell within the three weeks that her ring 
was in situ. A patch user appreciated that she could just take her supplies with her 
without worrying about logistics like temperature control. 
 Theme 2: Digital tracking tools (n=10). Most pill users relied (or planned to rely) 
on daily alarms on their phones or watches for reminders. As one participant described: 
“I had a timer on my watch and then added the difference to the time I would have taken 
my pill here [in the U.S.].” One practitioner of fertility-based awareness used a 
smartphone app to track her menstrual cycle. For almost all participants, these tools were 
already integrated into their contraceptive routines in the U.S. Therefore, women were 
confident and matter-of-fact in transferring them to the travel setting. 
 Theme 3: Adequate pre-travel supplies (n=10). These participants, mostly pill 
users, did not have to make any special arrangements to obtain enough contraceptives for 
their trip because their normal supply was adequate, even abundant. Some of them 
mentioned receiving multiple pill cycles at a time and one had enough pills to last four 
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months. Trip duration was a contributing factor: contraceptive supplies were only 
sufficient because these pill users were gone for six weeks or less. One Traveler 
explained, “I already had the pills that I needed. I didn’t have to say anything like ‘I need 
this many more because I’m going to be gone.’ It was just a few weeks.” Another woman 
clarified that she did not need any “long term” supplies. The remaining participants had 
enough patches or latex condoms to last their entire trip. 
 Theme 4: Pre-travel anticipation of contraceptive challenges (n=9). For some 
participants, preparing for travel included thinking about its potential impact on their 
contraceptive use. A few pill users commented on their plans to accommodate the time 
difference between their home and travel destination in their pill-taking schedule. Some 
of them sought guidance from a healthcare provider: “That was super helpful—her 
making that point that you have to adjust the time.” One participant contemplated 
skipping her placebo pills while conducting fieldwork in a remote area because “it’s less 
things to pack and less things to worry about” in terms of menstrual products. Another 
woman was mindful of how her bleeding patterns change with her stress levels: “I was 
aware of how that might affect me—thinking the IUD was working, if my period was late 
or early.” Two ring users knew they wouldn’t have reliable access to refrigeration while 
traveling and carefully mapped out their schedules as to avoid changing their ring during 
their trip. There were also two women who did not anticipate problems with their 
contraception, but traveled with their own supply of EC “just in case.” 
 Theme 5: Learning from past travel experiences (n=4). A few pill users 
described how their previous travel experiences—for example, maintaining a daily 
schedule while crossing multiple time zones—informed their contraceptive use on their 
index trip. One Traveler was more prepared after facing contraceptive barriers on 
previous trips: “I know it’s hard to keep track of what time you are supposed to take your 
pill. I had just taken a trip where I didn’t get my pills in time. For that reason, I make sure 
I have an advance supply more than the day before I leave on a trip.” Another woman 
traveled with her own supply of EC, a habit she developed during prior trips: “I always 
felt better having [EC] in my back pocket. If a condom broke, it was still going to be a 
vulnerable situation, but I had one measure of protection still available. Especially in a 
place where abortion would probably not be accessible.” 
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Barriers to contraceptive use 
 Apart from the challenges some participants faced when negotiating condom use 
with their travel sex partners, all barriers to contraceptive use related to pills.   
 Theme 1: Insurance and healthcare provider blockades (n=8). Many pill users 
faced obstacles from health insurance companies or healthcare providers while trying to 
secure enough contraception for their upcoming trip. Some insurance plans restricted the 
number of pill cycles that could be dispensed at one time, which left participants without 
enough pills to cover their entire trip: “I had already picked up a prescription within the 
month, so I could pay out of pocket or wait until the end of the week…but I was leaving 
town before that.” One woman leaving for a year-long study abroad program could only 
get enough pills for six months, the duration of her student health insurance policy; she 
unsuccessfully petitioned to access the additional six cycles she needed for her trip. Some 
participants were able to circumvent insurance-related barriers with multiple phone calls 
and assistance from pharmacists, but others were only left with the option to pay out of 
pocket for the contraception they needed. Participants also cited provider-related barriers: 
two were prescribed the wrong pill formulation and one of them only discovered this 
mistake after arriving at her travel destination. She experienced “really bad side effects,” 
depression and weight gain, which led her to discontinue the pill in the midst of traveling. 
Another participant was “too lazy” to acquire a refill before leaving and discontinued the 
pill during her trip. 
 Theme 2: Disruptions from air travel (n=6). Traveling across multiple time 
zones and on lengthy and complicated flight itineraries led to disruptions in some 
participants’ pill-taking routines. One experienced traveler remarked, “I tried to manage 
it alright and kind of calculate it out, but it’s always a struggle. There was a little 
confusion.” Another woman had to “start fresh” with her pill schedule while traveling 
because her usual time was in the middle of the night at her destination; she described the 
process as “tough” and “confusing.” One Traveler was so daunted by the “complete 
opposite” hours between her home and travel destination that she decided to stop taking 
the pill before she departed; she didn’t have sex while traveling, but regretted the return 
of her menstrual cramps.  
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 Some participants adhered well once they arrived, but became disoriented while 
traveling by plane: “You know, the days flying you forget. ‘Okay, we left on a Saturday, 
and by the time we got here it was still Saturday. Do I take one pill or two pills?’” 
Another succinctly remarked: “I was flying and I was like, ‘What time is it?!’” In 
addition to the pill users counted in this theme, there were others who did not consider 
the implications for their pill schedule: “I have no idea [about the time change]. I’m 
probably just going to take the risk and be like, ‘Whatever’s 24 hours later.’ We’re going 
to be traveling for an entire day.”    
 Theme 3: Pregnancy prevention not an immediate concern (n=5). Travelers 
who were not in sexual relationships during their trips expressed less diligence about 
their pill adherence. Four reported missing at least one pill during their trip. When 
discussing their pill lapses they used phrases such as “not a huge concern,” “not super 
careful,” “definitely intentional at times,” and “a little slack.” Two participants who 
traveled across multiple time zones admitted to giving no thought to the ramifications for 
their pill-taking schedule. Some women mentioned other motivations, besides pregnancy 
prevention, for staying on their pill regimen. One participant was primarily using the pill 
“for the skin and mental health—all those benefits.” Another continued using the pill to 
avoid the hormonal changes associated with discontinuing and restarting. Reflecting on 
her poor compliance, she described herself as only “kind of” using the pill. 
 
Discussion 
 
 This study leverages the strengths of qualitative research methods to explore 
young women’s SRH behaviors in the multifaceted context of international travel. We 
consider pre-departure factors as part of this context, including women’s expectations of 
sex. In non-travel settings, not expecting or planning sex is among the reasons women 
give for having sex without using contraception.34 Quantitative studies of female travelers 
find that unexpected sex is common—describing 32-75% of new sexual partnerships—
but report mixed findings for its association with risky sexual behavior.91,93,109,114,179 We 
provide several novel insights into the relationship between sex expectations, pre-travel 
preparations, and SRH behaviors that may inform future research. First, women provide 
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myriad rationales for anticipating abstinence, even when they are single and taking longer 
trips, and they only associate sex with leisure trips. Second, ambiguous expectations 
accommodate a theoretical possibility of sex and coincide with prevention behaviors such 
as taking condoms “just in case.” These first two findings are echoed in a qualitative 
study of Swedish women backpacking in Vietnam.181 Third, unexpected sexual 
encounters are typified by some healthy behaviors (i.e., condom use, partner 
communication) but also by unprotected sex, substance use, condom errors, and 
unintended pregnancy. Fourth, travelers use their expectations of abstinence to rationalize 
non-adherence and discontinuation of their hormonal contraceptive methods.  
 Our study points to some aspects of international travel that may facilitate new 
sexual relationships and sexual risk-taking. Many prior studies attribute travelers’ 
increased engagement in risky sexual behaviors to their desire for exploration, higher 
substance use, and perceptions of anonymity and liminality—phenomena that are also 
evident in our sample.78,80,182,183 Like other authors, we also find that these factors are not 
universally present or influential across women’s travel experiences.181,184,185 For 
example, the university students in our sample mostly report similar drinking habits for 
home and abroad. Additionally, those with new partners often engage their habitual (pre-
travel) STI and pregnancy prevention strategies and comfortably initiate sexual 
communication with their partners. Nonetheless, we observe significant SRH outcomes—
EC use, STI acquisition, unintended pregnancy, and abortion—for women who exhibit 
more susceptibility to the disinhibiting effects of travel. Priorities for future research 
include the development and validation of quantitative measures that capture the 
psychosocial and cultural environment of international travel. It is important that 
measures be evaluated across different destinations, trip types, and traveler populations to 
establish the range of their effects. With valid measures of these constructs, researchers 
can better evaluate their associations with SRH outcomes. An example comes from 
Marcantonio and colleagues, who developed a 12-item measure for “situational 
conditions”; higher scores represented more participation in a sexualized study-abroad 
environment.186 Scores helped to differentiate low-risk and high-risk pathways for 
students’ sexual behavior during travel. 
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 We make a significant contribution to the research literature with our data on 
women’s contraceptive attitudes, preparations, adherence, and experiences in the course 
of international travel. In this study, we observed an array of contraceptive considerations 
brought on by international travel—e.g., procuring extra supplies, adjusting schedules, 
and maintaining use during air travel—and obstacles that trigger contraceptive lapses and 
discontinuation. The logistical requirements of travel magnify differences in upkeep 
between methods; challenges are most acute for pill users, while travelers with IUDs 
appreciate their maintenance-free contraception. The literature will benefit from 
additional research into travel considerations for each contraceptive method type; 
women’s strategies for overcoming contraceptive obstacles before and during travel; and 
interventions to support women’s adherence to contraception while traveling. 
 
Clinical and policy implications 
 Travelers may seek healthcare prior to their departure to receive services 
indicated for their destination (e.g., vaccines), obtain prescription refills, or manage their 
chronic medical conditions. The pre-travel clinic visit offers a timely opportunity for 
SRH counseling. We urge greater recognition of contraceptive lapse and unintended 
pregnancy as potential health risks for female travelers of reproductive age, just as 
clinical guidelines acknowledge the potential for travel-associated STI.61 At a minimum, 
providers should raise the possibility of unexpected sexual encounters and inquire of 
travelers’ contraceptive plans, needs, and concerns. Hormonal method users should be 
encouraged to maintain strict adherence, even if they expect to be abstinent. We find that 
the days travelers spend in transit are particularly high-risk for pill lapse and that many 
women do not consider the implications of travel for their pill routines. Pill users need 
specific guidance customized to their itinerary, preferred time of day for pill taking, and 
time difference between their home and travel destination. The pre-travel visit is also an 
opportune time for clinicians to counsel women on EC use and offer them a dose to bring 
on their trip.67 EC is a safe, simple, and critical intervention for the prevention of 
unintended pregnancy following contraceptive failure, unprotected sex, or sexual assault. 
There is precedent for travel medicine clinicians to prescribe medications for travelers to 
use only if necessary—most commonly, antibiotics for diarrhea.187  
 89 
  Consistent with previous studies of non-traveling pill users, we find barriers 
associated with policies that restrict the number of cycles that women can receive at one 
time.188,189 The burden imposed on international travelers goes beyond frequent trips to 
the pharmacy. Women who anticipate being in another country when they are eligible or 
a refill must circumvent policy limits if they wish to have a sufficient contraceptive 
supply. Assistance from healthcare providers, pharmacists, and insurance companies is 
not guaranteed. Travel-associated barriers led some of our participants to discontinue the 
pill—a very significant event for women at risk of unintended pregnancy. We argue that 
the risks women potentially incur by traveling abroad without enough contraception far 
outweigh the costs of dispensing additional pill cycles.   
 
Limitations 
 Our findings should be considered in light of study limitations. First, qualitative 
studies do not aim for generalizability, but for a rich description of a particular sample—
in this case, female travelers attending a single U.S. university. Some of our insights may 
not apply to other populations of U.S. travelers, although a lack of comparable studies 
makes such an assessment difficult. Second, data collected from face-to-face interviews 
are subject to social desirability bias, particularly when related to sexual behavior.190 
While many of our participants report socially unsanctioned behaviors such as 
unprotected sex and multiple sex partners, we cannot be sure that all participants report 
these behaviors with honesty and accuracy. Third, qualitative analysis is an inherently 
subjective exercise where the investigator is the arbiter of “significance.” We cannot 
eliminate the possibility of investigator bias, even though we include safeguards such as 
double coding and verifying our conclusions though multiple checks of the data.  
  
Conclusion 
 The health of international travelers and the SRH of young women are the 
subjects of sizeable, but largely discrete, bodies of research. The nexus of these literatures 
deserves greater attention as researchers strive to pinpoint the situational and contextual 
influences over young women’s SRH. International travel is increasingly common and 
also distinguished by its sudden and potentially sweeping impact on the environment 
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surrounding women’s attitudes, decisions, behaviors, and health outcomes. Our study 
demonstrates that travel may amplify certain risk mechanisms for SRH, relative to what 
young women experience in their routine settings. While many research gaps remain, 
particularly for travelers’ contraceptive use, our findings suggest potential targets for 
intervention. Clinicians, study-abroad program administrators, and other practitioners 
who connect with young women prior to their departure should help women integrate 
SRH into their travel preparations. Even for international trips perceived as low-risk for 
SRH, these pre-travel interactions are opportunities to reinforce young women’s 
pregnancy/STI prevention strategies.    
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Table 17: Demographic, sexual and reproductive health-related, and travel-related 
characteristics of qualitative interview participants by travel status 
 Travel status 
 Pre-Traveler (n=19) Traveler (n=25) 
Age (years) 
Median (range) 
18-19 
20-21 
22-29 
 
20 (18-26) 
4 (21.1) 
10 (52.6) 
5 (26.3) 
 
21 (19-28) 
2 (8.0) 
13 (52.0) 
10 (40.0) 
Undergraduate student 15 (79.0) 18 (72.0) 
History of emergency contraception use 8 (42.1) 10 (40.0) 
History of international travela 18 (94.7) 23 (92.0) 
Relationship status prior to departure 
Single 
In a relationship 
 
13 (68.4) 
6 (31.6) 
 
10 (40.0) 
15 (60.0) 
Traveling with romantic partner 1 (5.3) 5 (20.0) 
Traveling alone 4 (21.1) 3 (12.0) 
Trip destination (region) 
Asia Pacific 
Central/South America 
Europe 
Mexico/Caribbean 
Other 
Multiple 
 
7 (36.8) 
3 (15.8) 
2 (10.5) 
1 (5.3) 
4 (21.1) 
2 (10.5) 
 
6 (24.0) 
9 (36.0) 
1 (4.0) 
1 (4.0) 
3 (12.0) 
5 (20.0) 
Trip purpose 
Academic 
Leisure 
Work/volunteer 
 
10 (52.6) 
5 (26.3) 
4 (21.1) 
 
18 (72.0) 
6 (24.0) 
1 (4.0) 
Trip duration  
Median (range) in days 
1 to 14 days 
15 to 30 days 
31 to 120 days 
121-365 days 
 
21 (5-210) 
3 (15.8) 
8 (42.1) 
7 (36.8) 
1 (5.3) 
 
90 (14-365) 
1 (4.0) 
8 (32.0) 
8 (32.0) 
9 (36.0) 
Contraceptive method(s) used on tripb 
Implant 
Intrauterine device 
Pill  
Patch 
Ring 
Condom 
Natural family planning 
 
1 (5.3) 
5 (26.3) 
8 (42.1) 
1 (5.3) 
2 (10.5) 
2 (10.5) 
0 (0.0) 
 
0 (0.0) 
7 (28.0) 
12 (48.0) 
0 (0.0) 
0 (0.0) 
9 (36.0) 
1 (4.0) 
aNot including the index trip. bCategories are not mutually exclusive. For Pre-Travelers, data represent 
anticipated travel methods.  
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Chapter 6 
 
  Discussion 
 
I. Strengths 
 
A. Public health significance 
Viewed through the lens of epidemiology, international travel is a high-frequency 
exposure in the US population. In 2016 alone, roughly 36 million women were “exposed” 
to traveling outside the United States.54,56 This dissertation evaluates the association 
between this common exposure and SRH outcomes of considerable consequence for 
adolescent and young adult women. Contraceptive lapse and new sexual partnerships 
with men contribute to the disproportionately high incidence of STI and unintended 
pregnancy for young women in the United States. Identifying, and then mitigating, travel-
associated SRH risks could improve health for the millions of annual US travelers and 
contribute to reductions in population SRH morbidity.    
International travel also carries significance for women’s SRH, specifically, 
because of the worldwide variation in the accessibility and quality of SRH services—i.e., 
contraception, condoms, EC, abortion, and STI testing and STI treatment. Some travelers 
do not need these services, bring their own SRH supplies, or only seek SRH services 
upon their return to the United States. However, some proportion of travelers will 
inevitably need to access critical SRH services during their trip and for them, 
international travel could be a highly vulnerable experience.     
 
B. Innovation 
This dissertation addresses research questions with little precedent in the 
epidemiological literature. Our review of the existing research on SRH and travel 
identified gaps for women traveling from the United States, travelers’ contraceptive 
behaviors, adjusted correlates of SRH outcomes during travel, and valid comparisons of 
travelers with non-travelers. We conceptualized an original research study that could 
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bridge each of those gaps. Furthermore, to maximize our contributions to the literature, 
we formulated study aims that were both hypothesis-testing and hypothesis-generating. 
Reflecting those aims, we took an innovative methodological approach that combined 
the strengths of quantitative and qualitative research methods.  
 
C. Methodology 
Manuscript 1. In our first manuscript, we isolate the effects of international travel 
on women’s risk of new sexual partnership and contraceptive lapse. Central to our 
approach is the use of Pre-Travelers as a counterfactual substitute for what Travelers 
would have experienced, had they remained in the United States. Several methodological 
strengths stem from our comparison of cross-sectional samples of Pre-Travelers and 
Travelers. First, we minimize confounding at the design stage by selecting a comparison 
group with a known propensity for travel. Second, we avoid both biased recall of pre-
travel behaviors (i.e., from a cross-sectional study of Travelers only) and priming of 
travel behaviors by pre-departure measures (i.e., from a prospective study following the 
same women from pre-travel to travel). Third, we integrate reference period duration—an 
important component of the counterfactual—into our survey design.  
Manuscript 2. Our second paper evaluates a wide range of factors that may 
influence young women’s risk of contraceptive lapse during their international travel. The 
key strength of this analysis is our selection of potential correlates based on behavioral 
theory, a robust literature on adolescents’ SRH, and emerging research describing 
travelers’ sexual behavior. We consider the contributions of women’s background 
characteristics, their pre-departure expectations, and multiple trip-related factors. We also 
include comprehensive measures for contraceptive lapse and its situational antecedents 
(e.g., getting off schedule with taking contraception, trouble communicating with male 
sex partners). Lastly, we confirm the consistency of our main findings in sensitivity 
analyses restricted to pill users and sexually active travelers.      
Manuscript 3. This paper adds critical context to the findings presented in our 
first two manuscripts. Using data from qualitative interviews, we describe phenomena 
that we could not have fully rendered with a purely quantitative approach. We consider 
many manifestations of SRH—e.g., expectations, concerns, behaviors, and experiences—
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for both the pre-travel and travel periods, and for multiple types of travel. Furthermore, 
we capture international trips characterized by high risk, low risk, and even protection 
from risk, relative to the United States. As a result, we generate hypotheses for an array 
of potential risk mechanisms affecting women’s SRH during travel.     
 
II. Limitations 
 
A. Study design 
 Temporality. There are limitations to our study that are inherent to cross-sectional 
designs. We cannot establish temporality among our survey measures for the reference 
period. For Manuscript 2 especially, we are limited in our ability to make inferences 
regarding causes of contraceptive lapse. We can confidently assume that background and 
pre-travel correlates temporally precede contraceptive lapses reported for the travel 
period. However, we cannot say the same for correlates assessed for the same trip.  
 Generalizability. We analyze data from a study comprised of female students 
from a single institution of higher education in Minnesota. Our findings may not be 
generalizable to students from other US institutions, although we have no evidence that 
this is the case. Generalizability is likely more limited for the broader population of 
young women (beyond college students) who engage in international travel.  
 
B. Measures  
 Misclassification (general). Most our survey measures are self-reported and 
retrospective. There are limited data on the reliability of retrospective SRH measures, 
especially for recall periods longer than six months. Recall may be suboptimal across our 
entire survey sample, leading to non-differential misclassification with respect to travel 
status. It is also possible that Travelers report more accurately because they have 
memorable travel experiences to anchor their recollections (recall bias).   
Misclassification (contraceptive lapse). Findings for two of our three manuscripts 
are predicated on accurate measures of contraceptive lapse, which we derive from 
multiple survey items related to women’s contraceptive use and sexual behavior. From 
the standpoint of data validity, it is best to measure contraceptive use in a diary or 
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calendar format that captures women’s contraceptive use at each coital event as well as 
overlap in her use of multiple methods. Such measurements were not feasible for our 15-
20-minute online survey. Thus, we take a conservative approach when classifying lapse 
for condom and withdrawal users, invariably misclassifying some true lapsers into the 
referent (non-lapse) group. In Manuscript 1, misclassification of lapse is likely non-
differential because Pre-Travelers and Travelers are both affected. However, 
misclassification preferentially affects sex-dependent methods and Pre-Travelers were 
more likely to have sex during the reference period. Thus, differential misclassification is 
also plausible. We assume the same for Manuscript 2 correlates; non-differential 
misclassification is likely, but we cannot rule out differential misclassification for 
variables associated with sex.     
 Social desirability. Data gathered through in-person interviews are typically more 
reliable than self-report, but are nevertheless susceptible to social desirability bias. 
Participants in our study may have been reluctant to share information that that they 
perceived to be embarrassing or socially unacceptable. We attempted to mitigate this 
threat by instructing interviewers to avoid leading questions or reacting in a way that 
connotes approval or disapproval. We also emphasized with participants that there were 
no “right” or “wrong” answers. Social desirability bias is also possible for the survey 
sample, but to a lesser degree. The anonymity provided by an online survey should 
reduce the likelihood of participants’ perceiving judgment of their responses. In all cases, 
we have no reason to suspect differential bias by travel status. 
 
C. Analysis 
 Statistical power. The existing literature on female travelers’ SRH only includes 
estimates for prevalence of new sexual partnerships, which we used as the basis for our 
power calculation. With no prior studies reporting on contraceptive lapse, we were unable 
to design our study in a way that would ensure adequate power for analyses treating lapse 
as an outcome. However, we hope that the novel estimates from our study will contribute 
to the design of future studies. 
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III. Implications 
 
A. Implications for research 
 This dissertation makes substantial contributions to the burgeoning literature on 
SRH during international travel. To our knowledge, it is the first study to compare female 
travelers and non-travelers with respect to risk of new sexual partnership and 
contraceptive lapse. These comparisons are fraught with methodological challenges, 
which we address in our design and analytic approach. Hopefully we can inform the 
design of additional comparative studies. Second, our descriptive analyses for the 
prevalence of travel-associated contraceptive lapse are also seemingly unprecedented. To 
date, studies have only considered condom use, leaving travelers’ pregnancy prevention 
behaviors shrouded in mystery. There are many ways to measure contraceptive use and 
adherence; there are both advantages and disadvantages to each approach. We hope that 
other investigators adopt and refine our schema to improve measures of travelers’ 
contraceptive use. Lastly, the exploratory analyses featured in this dissertation suggest 
many potential avenues for future research. As one example, prospective studies that 
clarify temporal relationships among travel measures could help determine whether the 
correlates we identify for contraceptive lapse are also risk factors. Our qualitative 
analyses spur numerous hypotheses for factors that may influence women’s SRH—
positively or negatively—during international travel. 
 
B. Implications for healthcare providers 
 We designed this study with healthcare providers in mind. In our sample, high 
proportions of travelers either visited a clinic for travel health services or had a routine 
provider for the SRH care. As detailed in our manuscripts, these clinical encounters are 
important windows for SRH counseling specific to international travel. In clinical 
practice guidelines for travel medicine, STIs and condom use receive much more 
emphasis than contraceptive use and unintended pregnancy. Our findings suggest that 
pregnancy prevention should be prioritized alongside STI prevention in the counseling of 
young women preparing for international travel.   
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 The clinical implications of our study extend to other settings in which travelers 
receive education and counseling. For example, student travelers often receive 
educational materials, pre-travel orientation, and on-site orientation that address health 
topics. These platforms, along with interpersonal exchanges between student travelers 
and travel program staff, should look for opportunities to address travelers’ SRH.      
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Appendix A 
 
Pilot survey session guide  
 
Instructions to participants: Please take this online survey. We guess it will take about 
15-20 minutes. Take note of where you get stuck, are confused, or don’t know how to 
answer the question; write down the question number on this piece of paper.  
 
1. Survey type:  ____Pre-Traveler ____Traveler 
 
2. Survey start time: 
 
3. Survey end time: 
 
4. Let’s start with the notes you made about where you got stuck. (PROBE: Tell me 
about why this was confusing. How could we rephrase the [question/response set] to 
make it less confusing? 
 
5. What questions made you feel uncomfortable? Can you think of a way to ask them 
differently that would make you feel less uncomfortable? 
 
6. What do you think about the length of the survey? (Too long? Short? Just right?) 
 
7. This study is focused on the sexual and reproductive health of international travelers. 
Was there anything missing – that is, something we should have asked, but didn’t? 
 
8. What questions would you delete, if any? 
 
9. What did you like about this survey? 
 
10. What other changes would you make to improve the experience of people like you 
taking this survey? 
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Appendix B 
 
Qualitative interview guide: Traveler 
 
Interviewer: Thank you for taking the time to talk to me. Before we start, I want to 
emphasize again that all questions are voluntary and you do not have to answer anything 
that makes you feel uncomfortable. If that happens, please let me know and we will move 
on to the next question. Also let me know if something’s unclear and I will explain it 
better. There are no right or wrong answers—you are the expert here! 
 
As I mentioned, the interview will be recorded. I’ll start that now. [Start recorder.] 
 
General  
 
1. First I’d like to hear about where you traveled. What was the best part of your trip? 
(PROBE: urban vs. rural areas, traveling companions, prior travel to destination) 
 
2. Tell me a little bit about the local culture. What are 2 or 3 things characterize 
[destination]? (PROBE: attitudes about sex, birth control, alcohol/drugs). How well 
do you speak the language? 
 
Travel concerns 
 
3. What were your top concerns during this trip when it comes to your health? (PROBE: 
illness, jet lag, accidents, etc).  
 
4. How concerned were you about sexually transmitted infections like chlamydia or 
HIV? What about pregnancy? Were these things you were concerned about before 
you traveled? 
 
Sexual relationships and pregnancy/STI prevention 
5. Now I’d like to talk about your romantic relationships during this trip. Did you have a 
sexual partner on this trip? (PROBE: New partner? Local?) Tell me about how you 
met. What conversations did you have about preventing pregnancy? STIs? 
 
6. What birth control method(s) did you use during your trip? Did you experience any 
problems using that method? Was there anything specific that helped you keep up 
with your birth control during this trip? (PROBE: supplies, refills, change in method 
due to travel considerations) 
 
7. Did you drink alcohol or use drugs on this trip? (If so: Do you think that using 
alcohol or drugs affected the decisions you made about having sex? How?) 
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Health services 
 
8. Did you seek out condoms in [travel destination]? If yes: Walk me through what you 
did. (PROBE: Where, with whom, how easy/difficult, quality.) If no: What do you 
think you would have done if you needed them? (PROBE: Where, with whom, how 
easy/difficult.) [Repeat for birth control other than condoms, EC, pregnancy testing, 
abortion].  
 
Conclusion 
 
9. Think back to the time just before you left for this trip and what you imagined it 
would be like. Now think specifically about your sexual and reproductive health – 
romantic relationships, birth control, pregnancy, and sexually transmitted infections. 
In what ways was this trip different than what you expected when it comes to your 
sexual and reproductive health? Does anything come to mind that we haven’t already 
discussed? 
 
10. What advice would you give to other female students who are preparing to travel 
abroad when it comes to their sexual and reproductive health? You can think back to 
your experiences on previous international trips as well, if that helps. 
 
11. Lastly, I have some questions about long-acting reversible contraception. Have you 
heard of the IUD or contraceptive implant that goes in your arm? If yes: Thinking 
about your international travel experience, do you think these methods would be 
suitable for travelers? Why or why not? 
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Appendix C 
 
Qualitative interview guide: Pre-Traveler 
 
Interviewer: Thank you for taking the time to talk to me. Before we start, I want to 
emphasize again that all questions are voluntary and you do not have to answer anything 
that makes you feel uncomfortable. If that happens, please let me know and we will move 
on to the next question. Also let me know if something’s unclear and I will explain it 
better. There are no right or wrong answers—you are the expert here! 
 
As I mentioned, the interview will be recorded. I’ll start that now. [Start recorder.] 
 
Travel preparation & information 
 
1. First I’d like to hear about your trip. Can tell me about it? (PROBE: Destination, 
traveling companions, duration, urban vs. rural areas) 
 
2. How familiar are you with the country and its culture? Tell me a little bit about what 
you know. (PROBE: attitudes about sex, birth control, alcohol/drugs). How well do 
you speak the language? 
 
3. What sources of information (like books or websites) have you consulted while 
preparing for this trip? (PROBE: for health information specifically?) 
 
4. Walk me through what happened at your travel medicine visit. What was helpful? 
What remaining concerns do you have? Did you discuss anything related to sexual 
health such as birth control, sexually transmitted infections, or pregnancy? If yes: 
What topics? Who initiated the conversation? How did you feel during the 
conversation? If no: What would you have thought if your provider brought up sexual 
health concerns for this trip?  
 
Travel concerns 
 
5. What are your concerns for this trip when it comes to your health? (PROBE: illness, 
jet lag, accidents, etc.)  
 
6. How concerned are you about sexually transmitted infections like chlamydia or HIV? 
What about pregnancy?  
 
Sexual relationships and pregnancy/STI prevention 
 
7. Do you think you’ll have sex during this trip? With whom? (PROBE: travel partner, 
new partner) (PROBE: If not, why not?) 
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8. What are you planning to use for birth control during this trip? (PROBE: supplies, 
refills, change in method due to travel considerations). What concerns do you have 
about your ability to use this method while traveling?  
 
9. Now I’d like to talk about local supplies and services in [destination]. Say you want 
to find condoms in [travel destination]. Walk me through what you would do. 
(PROBE: Where? With whom? How easy/difficult?) 
[Repeat for birth control other than condoms, EC, pregnancy testing, abortion].  
 
Conclusion 
 
10. Now, think back to all the trips you have taken outside the U.S. What are some 
memorable experiences you’ve had related to your sexual and reproductive health? 
These could be good, bad, or neutral experiences. 
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Appendix D 
 
Sensitivity analyses for Manuscript 2 
 
Table D1. Multivariable models estimating relative risk of contraceptive lapse for all 
participants, only pill users, and only participants who were sexually active with men 
during travel—Variables formatted to match main model. 
 
Table D2.  Multivariable models estimating relative risk of contraceptive lapse for all 
participants, only pill users, and only participants who were sexually active with men 
during travel—Variables re-formatted to address low sample size for subgroups.
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Table D1. Multivariable models estimating relative risk of contraceptive lapse for all participants, only pill users, and only participants who were 
sexually active with men during travel—Variables formatted to match main model.a 
 All (n=333) Pill users (n=166) Sexually active (n=103) 
 aRR 95% CI aRR 95% CI aRR 95% CI 
Duration of trip 
1 to 7 days  
8 to 30 days 
More than 30 days 
 
1.00 (ref.) 
1.39 
2.02 
 
 
0.76—2.54 
1.14—3.57 
 
1.00 (ref.) 
1.47 
2.04 
 
 
0.76—2.82 
1.11—3.76 
 
1.00 (ref.) 
1.19 
1.71 
 
 
0.30—4.78 
0.50—5.86 
Affected by language barriers 
Not at all  
A little 
Somewhat 
To a great extent 
 
1.00 (ref.) 
1.41 
1.44 
1.77 
 
 
0.94—2.13 
0.93—2.21 
1.02—3.08 
 
1.00 (ref.) 
1.35 
1.47 
1.89 
 
 
0.88—2.07 
0.95—2.29 
1.10—3.25 
 
1.00 (ref.) 
1.58 
0.85 
1.27 
 
 
0.82—3.05 
0.35—2.08 
0.18—9.11 
Perceived accessibility of abortion in destination 
Difficult to access  
Easy to access / Not sure / Neutral 
 
1.67 
1.00 (ref.) 
 
1.22—2.27 
 
1.53 
1.00 (ref.) 
 
1.12—2.08 
 
1.38 
1.00 (ref.) 
 
0.76—2.51 
Contraceptive method 
Pill 
Other/None 
 
4.51 
1.00 (ref.) 
 
2.57—7.94 
 
N/A 
1.00 (ref.) 
 
-- 
 
2.25 
1.00 (ref.) 
 
1.07—4.74 
 
Had trouble communicating with male sex partner about 
contraception 
Yes 
No 
 
 
1.79 
1.00 (ref.) 
 
 
1.16—2.75 
 
 
1.60 
1.00 (ref.) 
 
 
1.13—2.26 
 
 
2.17 
1.00 (ref.) 
 
 
1.20—3.93 
Had trouble maintaining contraception schedule due to 
travel across time zones 
Yes 
No 
 
 
1.38 
1.00 (ref.) 
 
 
1.00—1.91 
 
 
1.26 
1.00 (ref.) 
 
 
0.93—1.71 
 
 
1.52 
1.00 (ref.) 
 
 
0.82—2.79 
aModels include the same variables as the main model (Table 16), formatted in the same manner, to enhance comparability across models. However, small cell 
sizes in subgroup analyses (n<5, denoted in GRAY text) produce unstable estimates.  
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Table D2. Multivariable models estimating relative risk of contraceptive lapse for all participants, only pill users, and only participants who were 
sexually active with men during travel—Variables re-formatted to address low sample size for subgroups.a  
 All (n=333) Pill users (n=166) Sexually active (n=103) 
 aRR 95% CI aRR 95% CI aRR 95% CI 
Duration of trip (days) 1.00 1.00—1.00 1.00 1.00—1.00 1.00 1.00—1.00 
Affected by language barriers 
No (Not at all) 
Yes (All other categories) 
 
1.00 (ref.) 
1.59 
 
 
1.08—2.33 
 
1.00 (ref.) 
1.58 
 
 
1.07—2.35 
 
1.00 (ref.) 
1.41 
 
 
0.74—2.69 
Perceived accessibility of abortion in destination 
Difficult to access  
Easy to access / Not sure / Neutral 
 
1.60 
1.00 (ref.) 
 
1.17—2.20 
 
1.47 
1.00 (ref.) 
 
1.08—2.02 
 
1.34 
1.00 (ref.) 
 
0.75—2.39 
Contraceptive method 
Pill 
Other/None 
 
4.60 
1.00 (ref.) 
 
2.62—8.07 
 
N/A 
-- 
 
-- 
-- 
 
2.47 
1.00 (ref.) 
 
1.14—5.35 
 
Had trouble communicating with male sex partner about 
contraception 
Yes 
No 
 
 
1.76 
1.00 (ref.) 
 
 
1.17—2.66 
 
 
1.57 
1.00 (ref.) 
 
 
1.15—2.14 
 
 
2.04 
1.00 (ref.) 
 
 
1.16—3.60 
Had trouble maintaining contraception schedule due to travel 
across time zones 
Yes 
No 
 
 
1.40 
1.00 (ref.) 
 
 
1.02—1.93 
 
 
1.30 
1.00 (ref.) 
 
 
0.96—1.76 
 
 
1.42 
1.00 (ref.) 
 
 
0.78—2.57 
aModels include the same variables as the main model (Table 16), but variables are re-formatted to address small cell size in sub-groups (n<5, denoted in 
GRAY text).  
 
 
 
 
 
 
